Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016038	u-k	mmol/l (mmol/l)	2177	2976	0.44%
3016038	u-k	— (—)	384	424	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hypokalaemia

275

132

21.90

307.65

1.7

1.3

33.43

35.04

mmol/l

0.30

245

101

Other disorders of fluid, electrolyte and acid-base balance

1333

405

34.17

307.65

1.4

1.2

31.95

35.75

mmol/l

2.49

1154

329

Metabolic disorders

1006

808

7.71

307.65

1.5

1.2

32.89

37.28

mmol/l

4.02

873

698

Hypo-osmolality and hyponatraemia

1120

227

56.74

307.65

1.3

1.1

31.30

36.96

mmol/l

2.99

964

179

Malaise and fatigue

518

759

5.57

247.72

1.4

1.3

32.44

36.11

mmol/l

2.32

436

656

Implicit Sepsis

637

1339

3.63

176.91

1.4

1.2

32.78

34.87

mmol/l

1.26

541

1145

Endocrine, nutritional and metabolic diseases

460

429

5.47

175.61

1.4

1.3

33.91

38.97

mmol/l

2.75

405

383

Implicit Sepsis

657

1391

3.48

170.66

1.4

1.2

33.00

34.97

mmol/l

1.17

561

1196

Convulsions, not elsewhere classified

254

363

7.03

165.37

1.4

1.6

28.98

36.49

mmol/l

4.56

208

320

Anaemias

183

16.56

164.28

1.7

1.9

32.39

35.79

mmol/l

0.45

162

Substance abuse, excluding more controls

422

827

4.39

158.08

1.2

30.30

36.23

mmol/l

4.77

354

720

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

734

1640

3.11

157.16

1.4

1.3

32.10

35.33

mmol/l

2.86

627

1422

Condition for Implicit Sepsis (Organ dysfunction codes)

645

1403

3.27

150.76

1.4

1.2

33.22

35.07

mmol/l

1.05

557

1206

Condition for Implicit Sepsis (Organ dysfunction codes)

649

1397

3.23

147.50

1.4

1.3

33.03

35.18

mmol/l

1.32

564

1203

General symptoms and signs

663

995

3.36

143.13

1.3

33.75

35.83

mmol/l

1.11

568

876

Other bacterial diseases

693

1594

2.94

134.37

1.4

1.2

33.15

34.38

mmol/l

0.63

591

1377

Renal tubulo-interstitial diseases

644

1612

3.00

132.72

1.3

1.2

31.28

35.33

mmol/l

4.07

551

1387

Implicit bacterial Sepsis

407

949

3.75

123.76

1.5

1.2

33.40

35.16

mmol/l

0.68

347

803

Mental and behavioural disorders due to psychoactive substance use

433

1147

3.53

123.29

1.2

30.07

36.08

mmol/l

5.44

363

996

Exclusions for E4_PCOS_BROAD

226

395

5.85

123.10

1.7

1.4

34.07

36.80

mmol/l

0.72

202

354

Substance abuse

422

1129

3.54

121.39

1.2

30.30

36.03

mmol/l

4.86

354

982

Alcohol use disorder, Swedish definition

409

1044

3.63

120.85

1.3

1.2

31.44

36.16

mmol/l

3.25

342

912

Bacterial Sepsis

413

978

3.65

120.57

1.5

1.2

33.49

35.22

mmol/l

0.67

353

830

425

1099

3.53

120.03

1.3

1.2

31.04

36.24

mmol/l

4.08

354

954

Other bacterial diseases

685

1569

2.79

118.74

1.5

1.3

33.05

34.50

mmol/l

0.77

589

1359

Benzodiazepine use

674

1690

2.76

117.73

1.2

30.38

35.58

mmol/l

6.80

553

1474

Implicit bacterial Sepsis

377

892

3.79

117.47

1.4

1.2

33.39

35.02

mmol/l

0.58

320

755

Bacterial infection, other or unspecified

472

1226

3.29

117.26

1.5

1.2

33.10

34.75

mmol/l

0.78

402

1045

All kidney diseases

666

1651

2.78

116.98

1.4

1.3

31.23

35.52

mmol/l

4.66

583

1428

431

1127

3.40

114.20

1.3

1.2

31.25

36.08

mmol/l

3.62

359

982

Mental and behavioural disorders due to alcohol, excluding acute intoxication

345

902

3.85

113.61

1.2

31.36

36.44

mmol/l

3.14

288

785

Mental and behavioural disorders due to alcohol

373

996

3.63

112.09

1.2

30.98

36.55

mmol/l

4.03

311

869

Pneumonia, organism unspecified

622

1579

2.78

110.43

1.4

1.3

31.18

35.30

mmol/l

4.17

527

1374

Fever of other and unknown origin

360

868

3.72

109.78

1.7

1.3

33.50

36.35

mmol/l

1.26

320

758

Bacterial infection, other or unspecified

441

1186

3.26

108.86

1.5

1.2

33.33

34.74

mmol/l

0.59

373

1014

Pneumonias (Asthma/COPD co-morbidities)

661

1675

2.67

107.23

1.5

1.3

31.73

35.21

mmol/l

3.25

568

1462

All pneumoniae

663

1677

2.66

106.86

1.5

1.3

31.65

35.19

mmol/l

3.39

569

1465

Explicit Sepsis

372

992

3.54

106.52

1.6

1.2

32.10

35.30

mmol/l

1.86

326

847

Influenza and pneumonia

675

1639

2.63

105.40

1.5

1.3

31.72

35.11

mmol/l

3.14

581

1430

Aplastic and other anaemias

410

1171

3.30

105.18

1.3

1.2

32.44

35.04

mmol/l

1.35

350

986

Alcohol use disorder, ICD-based

315

824

3.86

104.58

1.2

31.05

36.06

mmol/l

3.00

261

723

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

648

1683

2.64

103.81

1.4

1.3

31.46

35.34

mmol/l

3.92

556

1471

Other anaemias

390

1118

3.36

103.20

1.3

1.2

32.41

35.08

mmol/l

1.34

330

936

Other and unspecified anaemias

387

1112

3.36

102.51

1.3

1.2

32.32

35.03

mmol/l

1.37

328

930

Cerebrovascular diseases (FINNGEN)

213

260

5.85

101.97

1.2

1.3

32.71

36.93

mmol/l

1.11

184

227

591

1289

2.79

101.48

1.5

1.2

31.92

34.92

mmol/l

2.26

507

1131

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

591

1289

2.79

101.48

1.5

1.2

31.92

34.92

mmol/l

2.26

507

1131

Hyperkalaemia

15.45

100.22

1.4

1.1

32.56

38.89

mmol/l

1.07

Disorders of other endocrine glands

374

1115

3.34

99.00

1.7

1.4

32.95

35.22

mmol/l

0.96

337

947

Syncope and collapse

314

712

3.81

97.87

1.4

1.2

34.35

35.88

mmol/l

0.46

267

611

Heart failure, not strict

528

1269

2.85

97.07

1.2

33.56

35.18

mmol/l

0.76

460

1091

Other septicaemia

337

939

3.49

95.28

1.7

1.2

32.16

34.46

mmol/l

1.06

294

806

Heart failure and antihypertensive medication

189

194

6.45

95.22

1.2

1.3

33.58

36.81

mmol/l

0.70

169

168

Septicaemia

364

1037

3.32

94.42

1.7

1.2

32.02

34.74

mmol/l

1.44

318

893

Headache

364

885

3.30

90.27

1.4

1.3

32.78

35.53

mmol/l

1.26

314

771

Other antidepressants

618

1228

2.59

87.69

1.3

33.12

35.69

mmol/l

1.66

509

1092

Mood disorders, excluding more controls

545

1215

2.69

87.28

1.3

1.2

31.32

35.35

mmol/l

3.29

454

1061

Nausea and vomiting

261

666

3.89

86.88

2.0

1.4

35.20

35.85

mmol/l

0.15

226

573

Any mental disorder

640

1274

2.53

85.90

1.3

32.98

35.24

mmol/l

1.41

545

1115

Hypertensive diseases (excluding secondary)

270

371

4.25

84.76

1.3

1.4

33.14

34.86

mmol/l

0.46

240

327

Persons encountering health services for specific procedures and health care

652

1629

2.41

84.00

1.6

1.3

33.83

34.46

mmol/l

0.26

573

1396

Pure hypercholesterolaemia

344

670

3.37

82.62

1.2

1.1

33.85

37.79

mmol/l

1.94

284

566

Anxiety disorders, excluding more controls

478

1134

2.76

82.19

1.3

1.2

32.64

35.05

mmol/l

1.20

413

989

Volume depletion

100

111

9.20

82.06

2.4

1.3

35.45

36.86

mmol/l

0.18

Other CVD (FINNGEN)

112

9.21

81.10

1.1

33.68

37.08

mmol/l

0.47

Disorders of lipoprotein metabolism and other lipidaemias

365

711

3.19

79.44

1.2

1.1

34.00

37.64

mmol/l

1.80

302

604

Injuries to the head

668

1787

2.31

78.84

1.3

1.4

33.69

34.37

mmol/l

0.27

561

1556

Bleeding

555

1617

2.46

77.81

1.4

1.2

33.01

34.77

mmol/l

0.93

464

1393

Constipation

570

1651

2.40

75.78

1.3

31.55

35.19

mmol/l

3.08

473

1431

Diseases of arteries, arterioles and capillaries (FINNGEN)

162

199

5.69

74.88

1.2

32.10

36.07

mmol/l

0.87

138

170

Intracranial trauma

349

800

3.09

74.76

1.3

1.5

33.38

35.75

mmol/l

0.91

297

705

Alcohol dependence

210

524

4.06

74.70

1.2

1.1

30.38

37.50

mmol/l

3.99

175

459

Acute tubulo-interstitial nephritis

420

1353

2.70

74.58

1.3

1.2

31.59

35.38

mmol/l

2.72

351

1154

Hypertension, essential

395

756

2.97

74.25

1.2

33.62

35.32

mmol/l

0.65

341

660

Symptoms and signs involving cognition, perception, emotional state and behaviour

574

1657

2.37

74.05

1.3

1.2

33.60

34.84

mmol/l

0.58

487

1438

Other heart diseases

243

400

3.99

73.91

1.5

1.6

36.93

35.43

mmol/l

0.32

225

356

Epilepsy

259

755

3.46

73.02

1.4

1.5

31.56

34.98

mmol/l

1.61

220

645

Depression or dysthymia

389

731

2.95

71.71

1.3

1.2

33.12

36.75

mmol/l

1.92

320

655

Cardiovascular diseases (excluding rheumatic etc)

294

486

3.50

71.38

1.6

1.9

35.16

35.21

mmol/l

0.01

266

434

Renal failure

363

1162

2.79

68.93

1.3

1.2

29.90

35.61

mmol/l

5.33

325

972

Osteopathies and chondropathies

392

1399

2.63

67.41

1.3

1.2

32.03

34.77

mmol/l

1.48

318

1202

Tramadol

449

1077

2.57

66.79

1.3

1.1

32.25

34.14

mmol/l

0.85

375

941

Anxiety (asthma-related co-morbidities)

326

859

2.95

66.69

1.4

1.5

31.87

35.51

mmol/l

1.68

281

761

Any death

441

1251

2.55

66.62

1.2

34.25

34.76

mmol/l

0.17

383

1066

Osteoporosis

260

752

3.28

66.07

1.3

1.2

31.72

33.98

mmol/l

0.80

204

636

Hypertension

392

801

2.78

65.47

1.2

1.3

33.26

35.36

mmol/l

0.89

341

705

Acute renal failure

206

558

3.75

65.43

1.3

1.2

29.81

34.54

mmol/l

2.39

188

456

Depression medications

120

8.66

65.35

1.5

1.4

34.34

35.80

mmol/l

0.15

109

Disorders of mineral metabolism

9.26

65.24

2.5

1.4

35.93

35.82

mmol/l

0.01

Psychiatric diseases

538

1128

2.40

65.17

1.3

33.73

35.64

mmol/l

0.97

461

994

Hypertensive diseases

392

804

2.77

65.07

1.2

1.3

33.24

35.31

mmol/l

0.88

341

708

Hypothyroidism, levothyroxine purchases

105

9.18

63.75

1.9

1.5

32.97

37.33

mmol/l

0.56

Hypothyroidism and >3 levothyroxin purchases

105

9.18

63.75

1.9

1.5

32.97

37.33

mmol/l

0.56

Oxycodone

276

813

3.10

63.73

1.3

1.1

34.86

34.54

mmol/l

0.08

237

700

Hypothyroidism (congenital or acquired)

105

9.17

63.68

2.4

1.5

33.16

37.33

mmol/l

0.52

All chronic kidney diseases

369

1145

2.65

62.81

1.3

1.2

30.15

35.77

mmol/l

5.02

331

974

Nutritional anaemias

358

1316

2.64

62.68

1.4

1.2

32.60

35.23

mmol/l

1.25

306

1112

Use of hypnotics and sedatives

589

1531

2.22

62.43

1.2

32.63

35.09

mmol/l

1.54

495

1336

Complications of surgical and medical care, not elsewhere classified

575

1800

2.20

62.35

1.4

1.2

32.85

34.68

mmol/l

1.02

493

1547

STROKE

341

826

2.83

62.20

1.2

1.1

32.24

34.78

mmol/l

1.04

297

703

Symptoms and signs concerning food and fluid intake

103

163

6.42

62.07

1.5

26.22

36.14

mmol/l

3.70

142

Oedema, not elsewhere classified

207

578

3.56

61.22

1.2

32.94

35.75

mmol/l

0.89

176

487

Infections, IBD-co-morbidities

116

131

6.39

60.68

1.7

1.3

29.66

40.49

mmol/l

3.45

105

116

Fall on same level

613

1567

2.14

59.10

1.3

1.4

32.71

34.88

mmol/l

1.37

514

1387

GASTRO-related operations

388

729

2.68

58.60

1.5

1.3

34.33

35.68

mmol/l

0.46

345

630

Any gastric operation

388

729

2.68

58.60

1.5

1.3

34.33

35.68

mmol/l

0.46

345

630

Diarrhoea and gastroenteritis of presumed infectious origin

422

1606

2.38

58.54

1.7

1.3

32.36

35.17

mmol/l

1.53

372

1377

Focal epilepsy

187

512

3.70

58.44

1.4

33.45

35.35

mmol/l

0.50

160

450

Cardiovascular diseases

260

418

3.36

58.23

1.6

2.0

34.94

36.48

mmol/l

0.36

242

374

Other disorders of adrenal gland

8.33

57.89

1.5

1.3

30.76

33.72

mmol/l

0.42

Other symptoms and signs involving cognitive functions and awareness

313

1060

2.71

56.92

1.3

1.2

33.18

35.04

mmol/l

0.74

263

895

First line medication for Crohn's disease

600

1528

2.13

56.81

1.4

1.3

32.76

34.93

mmol/l

1.35

519

1322

Secondary hypertension

8.92

56.72

1.3

29.47

38.00

mmol/l

1.79

Antihypertensive medication - note that there are other indications

257

411

3.33

56.55

1.4

2.1

34.29

36.37

mmol/l

0.56

236

376

Implicit viral Sepsis

222

693

3.24

56.52

1.8

1.2

32.19

35.57

mmol/l

1.23

199

594

Dental caries

185

491

3.66

56.48

1.6

1.3

30.28

35.95

mmol/l

2.52

162

428

Symptoms and signs involving the urinary system

471

1595

2.26

56.13

1.3

1.2

33.52

34.66

mmol/l

0.45

391

1374

Mood [affective] disorders

568

1742

2.12

55.83

1.3

31.21

34.87

mmol/l

3.10

475

1518

Intestinal infectious diseases

536

1912

2.14

55.58

1.6

1.3

32.32

34.82

mmol/l

1.55

473

1637

Intracranial injury

361

1384

2.48

55.49

1.3

34.25

34.67

mmol/l

0.11

306

1200

All anxiety disorders

330

997

2.63

54.90

1.4

31.83

34.68

mmol/l

1.21

285

868

Concussion

277

792

2.87

54.81

1.3

1.5

33.35

35.89

mmol/l

0.95

239

698

Mood disorders

567

1748

2.11

54.76

1.3

31.26

34.89

mmol/l

3.07

474

1523

Heart failure,strict

354

980

2.57

54.45

1.2

33.28

35.02

mmol/l

0.67

311

831

Paralytic ileus and intestinal obstruction

200

603

3.35

53.88

2.1

1.2

33.33

34.85

mmol/l

0.37

174

511

COPD (mode)

214

509

3.33

53.68

1.1

33.71

36.25

mmol/l

0.73

180

440

Other disorders of urethra and urinary system

396

1194

2.41

53.64

1.3

32.41

35.20

mmol/l

1.53

340

1032

Caries of dentine

167

435

3.77

53.53

1.5

1.2

29.46

36.14

mmol/l

3.15

146

378

Focal epilepsy, strict definition

174

482

3.66

53.52

1.4

33.95

35.28

mmol/l

0.31

149

424

Viral Sepsis

166

446

3.77

53.41

2.0

1.2

30.81

34.95

mmol/l

1.31

152

375

Iron deficiency anaemia

304

1147

2.63

53.16

1.4

1.2

32.64

35.08

mmol/l

1.04

261

964

Retention of urine

244

666

3.03

53.14

1.2

32.06

35.90

mmol/l

1.86

204

574

Implicit viral Sepsis

165

444

3.76

52.97

2.0

1.2

30.73

34.94

mmol/l

1.34

151

373

Depression

518

1644

2.14

52.88

1.3

32.07

34.75

mmol/l

1.70

435

1430

Anxiety disorders

489

1566

2.19

52.67

1.4

1.3

32.72

33.82

mmol/l

0.42

424

1351

Neurotic, stress-related and somatoform disorders

484

1552

2.19

52.53

1.4

1.3

32.77

33.75

mmol/l

0.36

419

1340

Dyspnoea

513

1791

2.13

52.28

1.2

32.78

34.63

mmol/l

0.96

428

1547

Diseases of oesophagus, stomach and duodenum

573

1657

2.08

52.27

1.3

1.2

32.22

34.90

mmol/l

1.93

489

1429

Early onset COPD, excluding more controls

139

335

4.19

51.90

1.2

1.1

32.52

37.21

mmol/l

1.23

117

296

Asthma, unspecified (mode), excluding more controls

274

728

2.83

51.74

1.2

30.52

36.22

mmol/l

4.01

226

640

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

537

1675

2.10

51.28

1.7

1.3

34.23

34.70

mmol/l

0.16

467

1454

Diseases of liver

241

840

2.90

50.73

1.2

30.64

35.26

mmol/l

2.54

211

719

Open wound of head

336

1327

2.46

50.72

1.3

34.93

34.48

mmol/l

0.12

277

1153

Schizophrenia or delusion, excluding more controls

170

475

3.57

50.62

1.2

27.73

35.77

mmol/l

4.71

144

406

Cerebrovascular diseases

458

1468

2.21

50.45

1.2

32.86

34.90

mmol/l

0.97

389

1252

Other functional intestinal disorders

298

1083

2.57

49.15

1.8

1.3

32.63

34.87

mmol/l

0.82

257

940

Diseases of the digestive system

312

1263

2.48

48.24

2.1

1.2

32.94

34.99

mmol/l

0.81

270

1068

Complications of procedures, not elsewhere classified

454

1766

2.14

48.09

1.4

1.2

32.74

34.79

mmol/l

1.08

394

1513

Pain, not elsewhere classified

160

450

3.58

48.06

1.5

1.3

35.73

35.48

mmol/l

0.04

132

390

Any reimbursement code in KELA

234

366

3.22

48.02

1.5

1.2

36.13

35.88

mmol/l

0.04

209

319

Certain infectious and parasitic diseases

489

1132

2.17

47.61

1.3

33.08

35.32

mmol/l

1.20

419

976

Complications of medical and surgical care

427

1824

2.16

47.59

1.5

1.2

33.74

34.03

mmol/l

0.09

374

1547

Persons encountering health services in other circumstances

245

889

2.76

47.29

1.3

1.2

31.74

34.81

mmol/l

1.28

208

751

Opioids

474

1132

2.18

47.25

1.3

1.2

35.47

34.09

mmol/l

0.55

399

993

Adrenocortical insufficiency

8.13

47.10

1.4

1.2

31.24

32.82

mmol/l

0.18

Asthma, unspecified (mode)

285

822

2.62

46.80

1.2

30.64

35.90

mmol/l

3.73

235

721

Other diseases of intestines

540

1511

2.04

46.53

1.7

1.3

34.23

34.76

mmol/l

0.18

471

1318

Dizziness and giddiness

410

1491

2.19

45.78

1.2

34.02

34.68

mmol/l

0.21

344

1280

Heart failure, strict

384

1209

2.26

44.72

1.2

33.10

35.27

mmol/l

1.01

335

1018

Parasetamol

346

718

2.45

44.28

1.2

1.5

34.02

36.13

mmol/l

0.78

294

641

Alcoholic liver disease

204

4.84

43.24

1.1

1.2

28.08

35.29

mmol/l

2.39

178

Persons encountering health services in other circumstances, wide

609

1644

1.91

42.87

1.4

1.3

33.11

34.75

mmol/l

0.86

528

1403

Focal epilepsy, mode (most common among epilepsy diagnosis)

152

447

3.44

42.78

1.5

1.4

33.36

35.69

mmol/l

0.58

133

391

Transplanted organ and tissue status

206

4.80

42.73

1.7

1.3

28.08

36.26

mmol/l

2.70

183

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

174

323

3.42

42.56

1.2

1.3

34.00

35.81

mmol/l

0.37

156

279

Other anxiety disorders

233

747

2.72

42.44

1.4

29.97

34.50

mmol/l

2.12

205

649

Codeine

437

1113

2.14

42.19

1.3

1.2

34.68

34.01

mmol/l

0.21

358

974

Pain in throat and chest

421

1183

2.15

41.96

1.2

1.3

34.15

34.54

mmol/l

0.11

351

1041

Hypopituitarism

146

5.60

41.90

2.2

1.5

33.37

36.35

mmol/l

0.48

136

Used for control exclusion in common control thyroid runs

517

1304

2.01

41.57

1.6

1.2

34.15

35.49

mmol/l

0.56

460

1134

COPD

290

981

2.43

41.56

1.2

32.83

35.46

mmol/l

1.10

242

837

ILD medications: prednisolone, methylprednisolone, prednisone

557

1615

1.94

41.45

1.4

1.2

31.95

34.97

mmol/l

2.22

469

1406

Abnormalities of breathing

442

1227

2.10

41.42

1.3

1.4

34.30

34.51

mmol/l

0.06

376

1084

Delirium, not induced by alcohol and other psychoactive substances

117

294

4.04

41.42

1.1

32.84

34.94

mmol/l

0.40

242

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

128

344

3.78

41.34

1.1

1.2

31.95

34.11

mmol/l

0.45

105

296

Alcohol withdrawal state with delirium

124

6.02

41.24

1.1

1.2

30.31

34.72

mmol/l

0.80

116

Care involving use of rehabilitation procedures

357

1509

2.19

40.99

1.5

1.3

33.17

34.57

mmol/l

0.54

323

1285

All-cause Heart Failure

371

1198

2.20

40.82

1.2

33.05

35.29

mmol/l

1.02

322

1009

Intestinal stricture

225

854

2.66

40.39

2.4

1.2

35.44

34.33

mmol/l

0.24

199

713

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

147

186

3.98

40.39

1.3

1.8

36.70

36.62

mmol/l

0.01

136

166

Autoimmune diseases excluding thyroid diseases

521

1450

1.97

40.36

1.5

1.3

32.89

35.16

mmol/l

1.27

457

1263

Implicit fungal Sepsis

134

5.73

40.22

1.4

1.1

31.53

36.69

mmol/l

1.13

110

Atrial fibrillation and flutter

140

240

3.80

40.19

1.2

1.1

33.49

36.25

mmol/l

0.60

123

206

Other diseases of urinary system

498

1412

1.99

40.09

1.4

1.3

33.19

35.11

mmol/l

0.97

421

1228

Alcohol abuse, main dg, excluding more controls

221

4.48

40.03

1.1

1.2

27.57

36.40

mmol/l

3.67

200

Other heart diseases, wide

442

1318

2.06

39.84

1.4

35.78

33.77

mmol/l

0.90

390

1144

ILD medications: immunosuppressive drugs

339

1438

2.20

39.65

1.5

1.4

32.09

35.13

mmol/l

1.49

293

1261

Other chronic obstructive pulmonary disease

279

958

2.42

39.50

1.2

32.80

35.58

mmol/l

1.15

233

815

Other or unspecified ileus, impaction or obstruction

142

422

3.40

39.33

2.4

1.2

33.80

35.63

mmol/l

0.35

125

352

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

128

354

3.62

39.22

1.5

1.2

28.49

35.52

mmol/l

2.70

110

311

Autoimmune diseases excluding thyroid diseases, strict definition

500

1393

1.97

39.08

1.5

1.2

33.29

35.17

mmol/l

0.90

437

1212

Hyperlipidaemia, other/unspecified

164

492

3.09

38.19

1.1

32.79

36.93

mmol/l

1.42

139

412

ILD medications

566

1641

1.88

38.17

1.4

32.36

35.09

mmol/l

1.84

478

1432

Other and unspecified iron deficiency

227

890

2.57

38.10

1.3

1.2

32.34

34.76

mmol/l

0.83

192

749

Other chronic obstructive pulmonary disease, including avohilmo

324

1212

2.22

37.91

1.2

32.42

35.12

mmol/l

1.28

270

1020

Examination and observation for other reasons

304

748

2.36

37.55

1.4

1.2

37.24

35.40

mmol/l

0.52

259

654

Asthma, excluding more controls

332

756

2.30

37.50

1.3

1.2

30.70

35.87

mmol/l

3.51

278

667

Covid-19 confirmed case

236

953

2.50

37.28

1.2

34.12

34.54

mmol/l

0.10

210

807

Non-invasive ventilation

115

270

3.83

37.01

1.2

1.4

31.46

39.00

mmol/l

2.27

237

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

343

1605

2.12

36.96

1.6

1.2

33.14

34.53

mmol/l

0.53

303

1354

Other neurological diseases

412

1618

2.01

36.89

1.4

1.2

33.85

34.51

mmol/l

0.22

356

1367

COPD/asthma/ILD related infections

499

1289

1.94

36.65

1.3

1.2

34.12

34.92

mmol/l

0.29

421

1131

COPD/asthma related infections

499

1289

1.94

36.65

1.3

1.2

34.12

34.92

mmol/l

0.29

421

1131

Fracture of lumbar spine and pelvis

174

609

2.88

36.45

1.3

1.1

33.52

35.22

mmol/l

0.45

141

506

Injuries to the abdomen, lower back, lumbar spine and pelvis

251

1042

2.40

36.37

1.3

1.2

33.02

34.92

mmol/l

0.67

207

884

Autoimmune diseases

540

1462

1.88

36.35

1.6

1.3

33.41

35.23

mmol/l

0.94

473

1273

Stroke, including SAH

373

1304

2.09

36.25

1.2

33.10

34.84

mmol/l

0.69

316

1106

Falls/tendency to fall

508

1330

1.92

35.91

1.3

1.4

32.24

35.04

mmol/l

1.84

430

1180

L04AD Calcineurin inhibitors

233

4.19

35.78

1.7

1.4

28.03

36.48

mmol/l

2.69

213

Hypertensive heart and/or renal disease

152

356

3.21

35.68

1.1

32.76

35.73

mmol/l

0.77

133

303

Cardiac arrhythmias

249

653

2.49

35.52

1.3

34.44

mmol/l

0.00

219

571

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

324

1526

2.13

35.51

1.4

1.2

32.94

34.87

mmol/l

0.80

285

1285

COPD, early/later onset

283

1053

2.28

35.36

1.2

32.76

35.34

mmol/l

1.07

236

883

Substance use, excluding alcohol

118

335

3.55

35.12

1.4

1.2

27.64

37.11

mmol/l

4.45

298

Cystitis

419

1247

2.01

35.07

1.4

1.3

31.99

35.18

mmol/l

2.03

349

1082

Selective serotonin reuptake inhibitors

467

1254

1.95

35.02

1.3

32.43

35.68

mmol/l

2.00

377

1118

General examination and investigation of persons without complaint and reported diagnosis

323

751

2.25

34.93

1.3

1.2

32.97

35.52

mmol/l

0.95

280

657

Provisional assignment of new diseases of uncertain etiology

292

1329

2.21

34.88

1.2

34.95

34.64

mmol/l

0.08

259

1128

Codes for special purposes

292

1331

2.20

34.75

1.2

34.95

34.64

mmol/l

0.08

259

1129

COPD differential diagnosis

367

862

2.14

34.73

1.2

33.42

35.84

mmol/l

1.05

315

756

ILD differential diagnosis

367

862

2.14

34.73

1.2

33.42

35.84

mmol/l

1.05

315

756

Other pulmonary diagnosis

367

863

2.14

34.63

1.3

1.2

33.48

35.82

mmol/l

0.98

314

761

Medical observation and evaluation for suspected diseases and conditions

328

754

2.23

34.55

1.4

1.2

33.56

35.53

mmol/l

0.72

267

660

Inflammatory bowel disease treatment related agents

562

1741

1.81

34.31

1.3

32.50

34.71

mmol/l

1.33

472

1516

Haemorrhage from respiratory passages

213

763

2.53

34.12

1.5

1.2

36.43

35.51

mmol/l

0.19

182

665

COPD related to multimorbidity

252

909

2.36

34.04

1.2

1.1

32.01

35.56

mmol/l

1.76

210

760

Excluding asthma or asthma-COPD overlap

365

863

2.13

34.00

1.2

33.31

35.82

mmol/l

1.10

311

761

Asthma

349

854

2.15

33.86

1.3

1.2

30.51

35.85

mmol/l

3.97

289

752

Hypertensive Heart Disease

140

341

3.24

33.85

1.1

33.89

36.07

mmol/l

0.44

120

290

COPD, hospital admissions

278

1050

2.25

33.82

1.2

33.04

35.28

mmol/l

0.86

232

880

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

369

1659

2.00

33.44

1.2

32.42

34.79

mmol/l

1.25

327

1398

Oral corticosteroids

518

1681

1.83

33.40

1.3

1.2

32.72

34.57

mmol/l

1.00

430

1457

Other reaction to severe stress, and adjustment disorders

175

646

2.72

33.22

1.5

1.2

33.98

34.78

mmol/l

0.14

155

560

Acute alcohol intoxication

151

516

2.95

33.15

1.2

27.12

37.29

mmol/l

7.14

122

457

Intestinal infectious diseases

571

1840

1.78

33.02

1.3

33.05

34.73

mmol/l

0.85

498

1576

Erysipelas

360

1364

2.02

32.72

1.2

1.1

33.95

34.39

mmol/l

0.12

302

1171

Generalized anxiety disorder

210

4.18

32.60

1.3

36.15

34.96

mmol/l

0.14

186

Exposure to unspecified factor

501

1996

1.81

32.42

1.3

32.44

34.55

mmol/l

1.16

412

1742

Atrial fibrillation and flutter with reimbursement

115

199

3.70

31.66

1.2

1.1

33.25

36.37

mmol/l

0.62

103

169

Other disorders of skin and subcutaneous tissue

378

1735

1.94

31.61

1.3

1.2

34.07

34.41

mmol/l

0.10

322

1474

Type 1 diabetes

152

535

2.86

31.55

1.8

1.3

30.93

35.95

mmol/l

2.16

141

475

Invasive ventilation

168

4.55

31.09

1.4

1.3

38.62

33.88

mmol/l

0.76

151

Insulin, fast-acting

217

919

2.38

30.93

1.7

1.2

30.82

35.86

mmol/l

2.95

194

784

Unspecified mental disorder

207

862

2.41

30.65

1.2

27.59

36.04

mmol/l

7.29

175

735

Hypotension

136

460

2.99

30.51

1.1

34.31

34.61

mmol/l

0.05

105

378

Other diseases of the digestive system

211

889

2.39

30.50

1.6

1.1

32.46

35.72

mmol/l

1.27

180

740

Kela-code for severe mental illness

192

775

2.49

30.46

1.2

27.09

35.79

mmol/l

7.06

161

662

Chronic kidney disease

203

825

2.43

30.34

1.4

1.2

29.96

35.95

mmol/l

3.60

183

677

Asthma (only as main-diagnosis), excluding more controls

289

756

2.19

30.23

1.3

1.2

31.34

35.87

mmol/l

2.54

241

667

Unspecified fall

292

1391

2.08

30.02

1.4

32.61

35.18

mmol/l

0.94

239

1187

Diabetes, varying definitions

491

1602

1.80

29.96

1.4

1.3

33.72

34.80

mmol/l

0.45

421

1382

Schizophrenia or delusion

170

653

2.62

29.91

1.2

27.73

34.88

mmol/l

4.24

144

565

Neuromuscular dysfunction of bladder

161

4.54

29.87

1.4

1.1

32.63

35.06

mmol/l

0.29

137

Personality disorders, excluding more controls

108

322

3.37

29.82

1.4

1.2

28.11

36.46

mmol/l

3.53

285

Other medical care

264

1101

2.17

29.74

1.4

1.2

35.44

35.33

mmol/l

0.03

228

923

GI-bleeding

208

882

2.38

29.65

1.6

1.1

32.53

36.02

mmol/l

1.36

175

732

Schizophrenia, schizotypal and delusional disorders

170

657

2.60

29.55

1.2

27.73

34.82

mmol/l

4.19

144

569

Diarrhoea and gastroenteritis of presumed infectious origin

495

1845

1.77

29.41

1.7

1.3

33.13

34.61

mmol/l

0.65

435

1578

Poisoning by drugs, medicaments and biological substances

131

443

2.98

29.36

1.5

1.3

27.99

35.54

mmol/l

3.81

112

389

Other CVD

148

537

2.78

29.19

1.1

1.2

34.86

34.76

mmol/l

0.01

116

449

Fungal Sepsis

6.48

29.16

2.0

1.1

32.57

36.79

mmol/l

0.59

Symptoms and signs involving the digestive system and abdomen

479

1323

1.82

29.00

1.3

33.67

35.28

mmol/l

0.73

408

1155

Poisoning by medicine

120

389

3.11

28.95

1.5

1.3

28.24

36.14

mmol/l

3.87

104

348

Lower back pain or/and sciatica

504

1879

1.76

28.94

1.2

33.07

34.31

mmol/l

0.55

424

1618

Diabetes mellitus

489

1607

1.78

28.86

1.4

1.3

33.69

34.80

mmol/l

0.46

420

1386

Diabetes medication

501

1685

1.77

28.80

1.4

1.3

33.50

34.78

mmol/l

0.58

429

1452

Dysphagia

156

587

2.68

28.66

1.3

1.1

33.44

35.61

mmol/l

0.54

131

500

Insulin, fast-acting or short human

218

957

2.29

28.65

1.7

1.2

30.80

35.66

mmol/l

2.82

195

809

Type 1 diabetes, wide definition, subgroup 1

124

412

3.03

28.63

2.0

1.3

30.79

35.32

mmol/l

1.58

115

367

Asthma (mode)

329

862

2.05

28.60

1.3

1.2

30.76

35.84

mmol/l

3.60

270

756

Osteoporosis with pathological fracture (FG)

197

4.09

28.55

1.2

1.1

28.81

33.65

mmol/l

1.14

157

Vocal cord dysfunction

124

4.81

28.54

1.2

1.3

33.29

37.63

mmol/l

0.72

112

Dialysis, with operation codes

101

298

3.43

28.50

1.5

1.2

31.50

35.13

mmol/l

0.68

258

Hard cardiovascular diseases

417

1338

1.87

28.47

1.2

1.3

34.37

33.84

mmol/l

0.16

372

1141

Recurrent or chronic depression

170

453

2.65

28.24

1.4

1.2

33.38

36.42

mmol/l

0.75

136

407

Asthma (only as main-diagnosis)

306

854

2.08

28.23

1.3

1.2

31.55

35.85

mmol/l

2.50

254

752

COPD, hospital admission 2, with asthma infections

201

727

2.39

28.12

1.2

1.1

32.86

35.71

mmol/l

1.00

166

601

Type 2 diabetes, wide definition

404

1391

1.87

28.08

1.2

1.1

33.35

34.86

mmol/l

0.67

344

1186

Hernia of abdominal wall, postoperative

291

3.43

28.03

2.0

1.1

33.43

35.00

mmol/l

0.22

242

Infections of the skin and subcutaneous tissue

288

1410

2.03

27.91

1.7

1.3

33.38

34.87

mmol/l

0.48

248

1221

Early onset COPD

139

500

2.80

27.89

1.2

32.52

34.66

mmol/l

0.46

117

430

Certain infectious and parasitic diseases

336

837

2.02

27.49

1.2

1.3

34.59

35.13

mmol/l

0.14

293

725

Organic, including symptomatic, mental disorders

312

1113

2.01

27.37

1.1

32.38

35.02

mmol/l

1.17

255

933

Gastrointestinal diseases

255

570

2.25

27.30

1.4

1.3

34.87

35.93

mmol/l

0.27

229

504

Low back pain

358

1353

1.91

27.25

1.3

1.2

31.85

34.79

mmol/l

1.67

300

1176

Injuries to the thorax

246

1160

2.13

27.11

1.2

33.95

34.94

mmol/l

0.26

195

984

Fracture of rib(s), sternum and thoracic spine

183

765

2.41

27.00

1.2

1.1

35.55

35.50

mmol/l

0.01

144

650

COPD, hospital admissions 3, with asthma pneumonia sepsis

174

598

2.51

26.99

1.2

1.1

32.91

35.69

mmol/l

0.86

143

502

Persons encountering health services for other counselling and medical advice, not elsewhere classified

518

1634

1.73

26.99

1.5

1.3

33.57

34.68

mmol/l

0.46

457

1397

Continuous positive airway pressure

240

3.46

26.94

1.3

1.5

35.02

38.77

mmol/l

0.67

208

Stroke, excluding SAH

336

1271

1.94

26.94

1.2

33.72

34.65

mmol/l

0.28

284

1077

Acute alcohol intoxication, ICD10

120

407

2.97

26.82

1.1

1.2

26.28

36.88

mmol/l

6.38

364

Erysipelas

281

1228

2.03

26.78

1.2

1.1

33.38

34.94

mmol/l

0.49

234

1050

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

458

1563

1.77

26.61

1.4

1.2

32.60

34.75

mmol/l

1.21

395

1347

Valvular heart disease excluding rheumatic fever

253

856

2.14

26.59

1.2

36.47

34.27

mmol/l

0.70

220

726

Insulin medication

320

1392

1.94

26.53

1.5

1.2

31.49

35.50

mmol/l

2.81

282

1190

Non-rheumatic valve diseases

250

842

2.15

26.53

1.1

1.2

36.45

34.37

mmol/l

0.63

217

713

Codeine or tramadol medication

520

1663

1.72

26.49

1.3

1.2

34.49

34.11

mmol/l

0.13

426

1436

Asthma-related pneumonia

224

1027

2.19

26.45

1.3

1.2

32.52

35.57

mmol/l

1.29

181

880

Asthma-related pneumonia or sepsis

224

1028

2.19

26.39

1.3

1.2

32.52

35.56

mmol/l

1.29

181

881

Asthma, hospital admissions 3, pneumonia

224

1028

2.19

26.39

1.3

1.2

32.52

35.56

mmol/l

1.29

181

881

Other diseases of pleura

265

1130

2.07

26.33

1.4

1.2

33.55

35.19

mmol/l

0.55

223

954

Gastroduodenal ulcer

163

653

2.51

26.22

1.3

1.1

32.55

36.39

mmol/l

1.08

130

540

Non-ischemic cardiomyopathy

192

657

2.37

26.10

1.2

32.21

34.76

mmol/l

0.81

164

548

Non-selective monoamine reuptake inhibitors

197

833

2.29

25.83

1.3

1.1

27.80

35.40

mmol/l

5.58

148

731

Neurological diseases, wide definition

124

194

3.22

25.81

1.3

1.7

35.90

38.36

mmol/l

0.41

116

178

Other and unspecified dermatitis

273

1367

2.01

25.65

1.2

1.3

31.47

34.96

mmol/l

1.88

237

1170

Neurological diseases

383

1030

1.87

25.50

1.3

1.5

35.10

35.29

mmol/l

0.05

334

905

Nonorganic sleeping disorders, excluding more controls

280

3.34

25.39

1.4

1.2

31.55

34.86

mmol/l

0.70

241

Dermatitis

313

1642

1.91

25.36

1.2

1.3

31.34

35.05

mmol/l

2.31

272

1407

Chronic pancreatitis

271

3.40

25.35

1.4

1.1

27.01

34.87

mmol/l

2.69

239

Iron deficiency anaemia secondary to blood loss (chronic)

113

383

2.98

25.34

1.5

1.2

32.80

33.99

mmol/l

0.23

314

Postmenopausal osteoporosis with pathological fracture

171

4.13

25.20

1.2

27.55

34.19

mmol/l

1.81

138

Traumatic subdural haemorrhage

251

3.44

25.02

1.2

1.1

32.84

36.71

mmol/l

0.77

209

Pain in limb

401

1499

1.80

24.99

1.3

33.31

34.20

mmol/l

0.29

337

1300

Type 1 diabetes, wide definition

127

464

2.75

24.72

2.0

1.4

31.08

35.59

mmol/l

1.61

118

408

Alcohol abuse, main dg

311

3.18

24.61

1.1

1.2

27.57

36.39

mmol/l

3.92

278

Other and unspecified myopathies

201

3.79

24.52

1.2

31.04

34.52

mmol/l

0.67

176

Insulin, combination of fast acting with intermediate-acting or long-acting

322

1574

1.88

24.52

1.5

1.2

31.48

35.59

mmol/l

3.04

283

1336

Abnormal findings on diagnostic imaging of lung

267

1290

1.99

24.48

1.2

32.70

35.17

mmol/l

1.06

235

1076

Episodal and paroxysmal disorders

505

1517

1.70

24.46

1.3

1.4

34.14

35.11

mmol/l

0.37

433

1321

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

193

863

2.25

24.42

1.6

1.3

32.99

34.60

mmol/l

0.42

172

735

Diseases of arteries, arterioles and capillaries

358

1449

1.83

24.31

1.2

31.95

35.22

mmol/l

1.99

306

1222

All influenza

144

567

2.56

24.20

1.8

1.3

31.93

36.25

mmol/l

1.35

127

498

Heart failure and coronary heart disease

256

887

2.06

24.07

1.2

34.11

34.15

mmol/l

0.01

223

732

Symptoms and signs involving the circulatory and respiratory systems

433

1231

1.77

23.98

1.2

1.4

34.98

34.45

mmol/l

0.17

378

1088

Abdominal and pelvic pain

455

1321

1.73

23.70

1.2

1.3

32.48

35.32

mmol/l

1.65

391

1153

Candidiasis

161

676

2.40

23.60

1.5

1.2

30.24

34.92

mmol/l

2.19

136

578

Problems related to lifestyle

167

3.99

23.35

1.2

1.1

26.99

35.52

mmol/l

2.38

150

Diabetes, insulin treatment (Kela reimbursement)

483

1743

1.68

23.34

1.4

1.2

32.64

34.86

mmol/l

1.33

416

1496

Later onset COPD, excluding more controls

133

385

2.69

23.33

1.1

33.30

36.72

mmol/l

0.94

110

326

Polyuria

131

502

2.63

23.32

1.3

1.1

35.08

35.25

mmol/l

0.03

107

433

Diverticular disease of intestine

349

1217

1.84

23.24

1.2

1.1

33.43

34.73

mmol/l

0.43

284

1043

Hypothyroidism, strict autoimmune

327

1154

1.87

23.16

1.3

1.2

33.74

35.35

mmol/l

0.60

268

990

Mental and behavioural disorders due to sedatives or hypnotics

110

4.79

23.15

1.5

1.1

25.36

37.67

mmol/l

3.31

101

Asthma (diagnoses ohter than nonallergic)

416

2018

1.71

23.11

1.3

1.4

30.84

34.92

mmol/l

3.61

345

1754

Factors influencing health status and contact with health services

136

242

2.83

23.08

1.3

1.2

36.27

38.81

mmol/l

0.50

123

219

Insulin, intermediate and long-acting

287

1472

1.90

23.05

1.6

1.2

30.76

35.51

mmol/l

3.61

252

1246

Asthma, hospital admission 2, infections

300

1576

1.87

22.94

1.3

31.91

35.53

mmol/l

2.26

242

1363

Asthma-related infections

300

1576

1.87

22.94

1.3

31.91

35.53

mmol/l

2.26

242

1363

Artificial opening status

119

4.63

22.93

3.7

1.3

47.89

34.65

mmol/l

2.23

105

Alcohol-induced chronic pancreatitis

111

4.76

22.92

1.3

1.2

24.04

35.48

mmol/l

2.83

101

Nephropathy related operations

301

3.13

22.68

1.6

1.2

31.46

34.41

mmol/l

0.47

267

Fracture of shoulder and upper arm

214

1027

2.09

22.61

1.4

1.2

31.86

35.24

mmol/l

1.42

180

879

Cough

209

938

2.12

22.59

1.3

1.5

35.59

34.82

mmol/l

0.17

172

821

Other external causes of accidental injury

359

985

1.83

22.34

1.3

1.4

33.25

35.13

mmol/l

0.77

311

878

Other special examinations and investigations of persons without complaint or reported diagnosis

291

754

1.96

22.22

1.2

32.70

35.53

mmol/l

1.15

250

660

Accidents

358

985

1.83

22.09

1.3

1.4

33.45

35.13

mmol/l

0.65

311

878

Disorder of lipoprotein metabolism, unspecified

148

4.09

21.97

1.3

1.1

28.77

38.20

mmol/l

2.82

118

Heart failure and bmi 25plus

185

555

2.26

21.91

1.2

1.1

34.99

34.52

mmol/l

0.09

155

461

Symptoms and signs involving the nervous and musculoskeletal systems

293

1585

1.86

21.91

1.5

1.3

33.28

34.79

mmol/l

0.49

256

1344

Other and unspecified nonorganic psychotic disorders

329

2.97

21.76

1.3

1.2

29.37

36.30

mmol/l

2.25

294

Disorders of lens

320

1084

1.85

21.69

1.2

32.72

34.52

mmol/l

0.70

281

932

Intestinal adhesions without obstruction

163

3.92

21.67

1.9

1.2

35.13

35.02

mmol/l

0.01

138

Persons encountering health services for examination and investigation

291

754

1.94

21.59

1.3

1.2

35.50

35.53

mmol/l

0.01

247

660

Candidiasis

300

3.06

21.50

1.8

1.2

30.42

34.57

mmol/l

1.12

259

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

128

505

2.55

21.48

1.5

1.2

28.49

35.93

mmol/l

3.06

110

444

Sciatica+with lumbago

243

1142

1.97

21.36

1.2

34.65

34.83

mmol/l

0.04

204

993

Genitourinary diseases

263

660

2.00

21.33

1.4

1.5

36.35

36.12

mmol/l

0.05

247

590

Type 2 diabetes

438

1524

1.68

21.31

1.2

32.92

34.79

mmol/l

0.90

370

1307

Diseases of the myoneural junction and muscle

302

3.05

21.28

1.3

31.62

35.42

mmol/l

0.90

261

Other degenerative diseases of the nervous system

146

447

2.45

21.19

1.2

32.46

35.76

mmol/l

0.91

119

380

Chronic lower respiratory diseases

544

1820

1.60

21.04

1.3

1.4

32.08

34.93

mmol/l

2.08

456

1589

Viral pneumonia

258

3.21

20.97

2.8

1.3

30.61

35.55

mmol/l

1.24

231

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

124

482

2.56

20.90

2.1

1.8

36.09

34.99

mmol/l

0.16

110

429

Ascites

163

3.86

20.89

1.3

1.1

35.27

36.99

mmol/l

0.18

141

Other bacterial intestinal infections

134

549

2.46

20.81

1.6

1.2

32.66

35.98

mmol/l

0.89

117

459

Spondylopathies

369

1263

1.75

20.75

1.2

33.74

35.06

mmol/l

0.50

313

1091

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

280

3.09

20.75

1.4

1.2

28.62

36.17

mmol/l

2.40

254

Sequelae of cerebrovascular disease

207

869

2.07

20.63

1.2

1.1

33.20

35.87

mmol/l

0.83

172

728

Exclusions for E4_PCOS_CONSORTIUM

342

1208

1.78

20.52

1.6

1.3

35.18

33.99

mmol/l

0.38

294

1040

Other diseases of blood and blood-forming organs, wide

136

565

2.43

20.51

1.6

1.2

31.16

34.60

mmol/l

1.16

118

487

Psychotic depression

5.39

20.42

1.1

32.56

36.37

mmol/l

0.48

Hypothyroidism, other/unspecified

406

1588

1.69

20.40

1.5

1.2

34.02

35.08

mmol/l

0.40

340

1360

Neoplasms

315

908

1.84

20.39

1.4

1.6

34.77

33.91

mmol/l

0.23

288

792

Disorders of thyroid, IBD co-morbidities

136

3.69

20.35

1.2

33.35

40.54

mmol/l

1.41

120

Other bacterial intestinal infections

114

438

2.62

20.27

1.7

1.2

32.88

35.61

mmol/l

0.60

102

356

Pain (limb, back, neck, head abdominally)

333

923

1.81

20.15

1.2

1.4

33.97

35.85

mmol/l

0.69

292

818

Gastric ulcer

112

428

2.64

20.13

1.3

1.1

32.63

36.05

mmol/l

0.64

351

Superficial injury of head

137

577

2.39

20.02

1.3

33.13

34.99

mmol/l

0.35

105

490

Spinal stenosis

266

1076

1.89

19.97

1.1

33.13

35.06

mmol/l

0.73

231

918

Other headache syndromes

195

948

2.06

19.96

1.3

1.2

34.93

34.67

mmol/l

0.05

170

811

Type of accident

158

710

2.24

19.87

1.4

1.2

33.57

34.81

mmol/l

0.24

135

610

Ischaemic Stroke, excluding all haemorrhages

299

1232

1.81

19.81

1.2

34.29

34.64

mmol/l

0.09

251

1044

Other arrhythmias

274

1114

1.86

19.80

1.2

34.68

33.88

mmol/l

0.21

233

947

External causes of morbidity and mortality

281

744

1.90

19.60

1.3

1.4

32.85

35.44

mmol/l

1.12

248

658

Other soft tissue disorders, not elsewhere classified

430

1530

1.65

19.54

1.3

1.4

32.83

34.36

mmol/l

0.62

365

1330

Benign neoplasm of other and unspecified endocrine glands

308

2.92

19.36

1.3

1.2

33.56

35.57

mmol/l

0.34

262

Transient ischemic attack

276

1223

1.83

19.29

1.1

1.2

33.35

34.76

mmol/l

0.47

230

1034

Diseases of the eye and adnexa

324

903

1.80

19.28

1.3

1.4

34.48

34.89

mmol/l

0.10

291

798

Hypothyreosis and Thyroxine purchase for inclusion criteria

418

1669

1.65

19.26

1.4

1.2

34.06

34.78

mmol/l

0.26

349

1430

Gastro-oesophageal reflux disease

313

1542

1.76

19.19

1.3

1.2

33.49

34.85

mmol/l

0.51

267

1324

Suicide or other Intentional self-harm

115

457

2.53

19.08

1.4

1.2

28.19

35.45

mmol/l

2.96

403

513

1683

1.58

18.92

1.3

1.2

34.11

34.39

mmol/l

0.09

430

1462

Pneumonitis due to solids and liquids

189

3.48

18.91

1.4

1.2

32.63

34.17

mmol/l

0.22

163

Peripheral artery disease

244

1032

1.89

18.70

1.1

32.23

35.43

mmol/l

1.40

202

857

Disorders of the thyroid gland

419

1676

1.63

18.62

1.4

1.2

33.86

35.02

mmol/l

0.46

353

1442

Missing teeth due to accident, extraction or parodontitis

296

1590

1.76

18.55

1.2

31.80

34.68

mmol/l

1.62

242

1355

Ischemic heart diseases

391

1413

1.67

18.53

1.2

1.3

35.69

33.56

mmol/l

0.92

343

1210

Mycoses

145

649

2.25

18.46

1.5

1.2

30.76

35.41

mmol/l

2.01

127

559

Nontraumatic intracranial haemmorrhage

126

532

2.39

18.37

1.2

1.1

30.23

35.41

mmol/l

1.87

105

440

Supplementary factors related to causes of morbidity and mortality classified elsewhere

162

760

2.14

18.34

1.4

1.2

33.82

35.12

mmol/l

0.26

139

655

COPD, hospital admissions 1, only main diagnosis

190

803

2.04

18.27

1.1

35.51

35.23

mmol/l

0.05

154

670

Polyneuropathies and other disorders of the peripheral nervous system

129

553

2.35

18.20

1.2

32.61

35.61

mmol/l

0.71

113

472

Other complications of surgical and medical care, not elsewhere classified

194

3.39

18.16

2.6

1.2

35.07

36.18

mmol/l

0.12

170

Viral and other specified intestinal infections

127

521

2.36

18.07

2.2

1.6

33.69

35.94

mmol/l

0.47

120

455

Pleural effusion

100

382

2.64

18.06

1.2

1.1

35.33

35.24

mmol/l

0.01

328

Volvulus

5.96

17.98

1.7

1.1

30.74

36.32

mmol/l

0.74

Fracture of skull and facial bones

108

429

2.53

17.98

1.4

1.2

29.88

36.46

mmol/l

2.02

370

Bacterial intestinal infections, IBD co-morbidities

115

472

2.46

17.88

1.7

1.2

33.09

34.93

mmol/l

0.37

104

391

Follow-up examination after treatment for conditions other than malignant neoplasms

193

627

2.04

17.83

1.3

1.1

33.17

35.38

mmol/l

0.62

163

543

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

188

3.39

17.63

1.4

1.3

33.73

35.66

mmol/l

0.26

164

Periodontitis

433

1821

1.59

17.62

1.2

31.52

34.74

mmol/l

2.36

371

1562

Abnormalities of heart beat

166

785

2.08

17.42

1.2

34.63

34.89

mmol/l

0.05

141

675

Senile cataract

289

999

1.78

17.35

1.2

1.1

32.19

34.46

mmol/l

0.98

252

849

Other noninfective gastroenteritis and colitis

140

634

2.22

17.32

2.3

1.3

32.72

34.92

mmol/l

0.48

126

541

Other acute lower respiratory infections

259

1384

1.79

17.25

1.9

1.3

35.85

34.81

mmol/l

0.27

222

1187

Schizophrenia

301

2.81

17.17

1.4

1.2

27.44

36.71

mmol/l

3.56

267

severe traumatic brain injury, does not include concussion

130

574

2.28

17.14

1.2

35.34

35.77

mmol/l

0.06

102

477

Malnutrition

5.71

17.08

1.7

1.5

32.77

35.20

mmol/l

0.21

Ulcer of lower limb, not elsewhere classified

347

2.68

17.07

1.2

1.1

31.40

34.50

mmol/l

0.67

287

Other/unspecified dorsalgia

178

882

2.01

17.01

1.3

1.2

32.81

35.56

mmol/l

0.93

155

755

Sequelae of external causes of morbidity and mortality

143

659

2.18

17.00

1.4

1.2

28.90

35.70

mmol/l

3.50

127

563

Ischaemic heart disease, wide definition

359

1342

1.66

17.00

1.2

1.1

35.08

33.93

mmol/l

0.38

306

1140

Noninfective enteritis and colitis

222

1195

1.86

16.97

2.2

1.3

34.15

35.00

mmol/l

0.19

195

1027

Nerve, nerve root and plexus disorders

465

1831

1.56

16.95

1.2

31.78

34.99

mmol/l

2.32

392

1570

Injuries to the hip and thigh

250

1261

1.80

16.92

1.3

1.2

34.65

34.68

mmol/l

0.01

204

1063

Sub-endpoint used in defining T1D endpoints

152

706

2.13

16.91

1.8

1.3

30.96

35.65

mmol/l

2.09

142

594

Diseases of the respiratory system

277

768

1.81

16.87

1.3

1.2

34.12

35.97

mmol/l

0.59

238

672

Fibrosis and cirrhosis of liver

174

3.44

16.85

1.1

1.2

35.61

33.74

mmol/l

0.23

148

Persons encountering health services for specific procedures, not carried out

137

3.76

16.70

2.0

1.1

29.30

34.11

mmol/l

0.76

123

Chronic periodontitis, including avohilmo

428

1826

1.57

16.59

1.2

31.56

34.72

mmol/l

2.26

366

1568

Other cataract

214

856

1.90

16.56

1.2

33.90

34.97

mmol/l

0.28

189

734

Cutaneous abscess, furuncle and carbuncle

128

570

2.26

16.55

1.5

1.3

33.36

35.03

mmol/l

0.41

113

501

Vascular disorders of the intestines

129

3.84

16.52

1.2

1.1

37.60

35.76

mmol/l

0.17

106

Dorsalgia

415

1391

1.60

16.50

1.2

1.3

34.01

35.13

mmol/l

0.40

355

1213

Other gastritis (incl. Duodenitis)

124

546

2.29

16.48

1.4

1.1

29.79

35.62

mmol/l

2.04

111

454

Paroxysmal tachycardia

238

2.86

16.47

1.4

31.86

37.09

mmol/l

1.27

209

Unspecified haematuria

202

876

1.92

16.41

1.3

1.2

34.08

35.43

mmol/l

0.30

164

758

Aneurysms, operations, SAH

389

2.54

16.41

1.2

27.83

34.98

mmol/l

3.19

328

Mycoses

372

2019

1.61

16.40

1.3

1.2

32.43

34.31

mmol/l

0.96

316

1745

L04AA Selective immunosuppressants

120

523

2.31

16.34

1.6

1.2

30.19

35.12

mmol/l

1.42

104

451

L04AX Other immunosuppressants

256

1458

1.76

16.31

1.4

31.97

34.88

mmol/l

1.26

217

1260

Autoimmune diseases related-to ILD

374

2002

1.60

16.27

1.4

1.2

33.28

34.37

mmol/l

0.39

314

1727

Dermatitis and eczema

491

2002

1.52

16.21

1.3

30.70

35.00

mmol/l

4.16

418

1732

Other general symptoms and signs

4.94

16.19

1.2

2.3

35.63

35.35

mmol/l

0.02

208

1107

1.87

16.14

1.4

31.75

36.01

mmol/l

2.08

170

959

Bacterial pneumoniae

194

892

1.92

16.09

1.3

1.2

30.74

35.36

mmol/l

2.21

167

765

Bronchitis

471

1939

1.53

16.06

1.3

33.82

34.25

mmol/l

0.14

396

1675

Atherosclerosis, excluding cerebral and coronary sclerosis

224

966

1.84

15.97

1.1

32.55

35.74

mmol/l

1.24

185

797

Other and unspecified polyneuropathies, also in other diseases

112

479

2.36

15.96

1.2

1.1

33.16

35.46

mmol/l

0.43

411

Major coronary heart disease event excluding revascularizations

298

1165

1.71

15.95

1.2

1.1

35.69

34.47

mmol/l

0.35

248

976

237

2.97

15.89

1.7

1.1

35.97

35.18

mmol/l

0.09

197

Fall on and from stairs and steps

136

632

2.16

15.86

1.2

29.90

35.62

mmol/l

2.20

107

538

Coronary atherosclerosis

308

1153

1.70

15.83

1.2

1.1

35.01

34.07

mmol/l

0.28

267

968

Other dorsopathies, not elsewhere classified

421

1398

1.58

15.74

1.2

1.3

33.48

35.12

mmol/l

0.65

350

1220

Explicit bacterial Sepsis

202

3.15

15.71

1.5

1.2

33.68

36.74

mmol/l

0.44

170

Disorders of adult personality and behaviour

114

495

2.31

15.65

1.4

1.3

29.48

35.19

mmol/l

1.91

431

Panic disorder

193

3.18

15.54

1.2

30.45

36.01

mmol/l

1.05

169

Spondylosis

252

1171

1.76

15.53

1.2

1.1

34.24

35.11

mmol/l

0.25

212

1006

Leisure time condition

103

430

2.41

15.50

1.3

1.2

32.68

35.52

mmol/l

0.53

376

Hypoplasia of dental enamel

5.89

15.43

2.2

3.0

26.42

39.62

mmol/l

1.80

Bacterial pneumonia, not elsewhere classified

184

843

1.93

15.40

1.3

1.2

31.61

35.50

mmol/l

1.61

158

721

Second line medication for Crohn's disease

258

1499

1.73

15.36

1.4

31.86

34.66

mmol/l

1.20

219

1298

Asthma/COPD (KELA code 203)

412

1818

1.56

15.34

1.2

1.4

32.15

34.90

mmol/l

1.75

343

1587

COPD-related respiratory insufficiency

276

2.78

15.23

1.2

1.1

33.28

35.27

mmol/l

0.30

235

Personality disorders

108

464

2.34

15.21

1.4

1.2

28.11

35.55

mmol/l

3.07

406

Other and unspecified drugs and medicaments

181

3.24

15.17

1.4

1.2

33.57

35.47

mmol/l

0.24

159

Diseases of the skin and subcutaneous tissue

430

1385

1.56

15.16

1.3

34.65

35.08

mmol/l

0.13

356

1216

Type 2 diabetes, definitions combined

399

1491

1.57

15.13

1.2

33.69

34.81

mmol/l

0.41

333

1277

Other retinal disorders

313

1483

1.65

15.11

1.1

1.2

31.87

35.23

mmol/l

1.94

265

1251

Bipolar affective disorders

288

2.72

15.10

1.2

23.63

36.51

mmol/l

6.51

251

Presence of other functional implants

292

1206

1.69

14.97

1.3

1.1

31.97

34.83

mmol/l

1.43

240

1027

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

111

3.53

14.96

1.3

1.1

33.58

38.39

mmol/l

0.74

Polyarthropathies

300

1172

1.68

14.94

1.2

32.22

34.96

mmol/l

1.24

253

1019

Undetermined asthma, excluding more controls

204

3.06

14.80

1.3

1.1

34.02

37.37

mmol/l

0.64

180

Cellulitis

117

527

2.23

14.79

1.4

1.2

32.52

34.95

mmol/l

0.54

101

460

Enterocolitis due to Clostridium difficile

259

2.81

14.70

1.6

1.2

30.48

34.77

mmol/l

1.16

214

Bacterial pneumonia (organism specified)

215

1087

1.80

14.59

1.3

1.2

31.19

35.31

mmol/l

2.03

186

918

Subarachnoid haemorrhage

233

2.90

14.56

1.2

28.38

34.79

mmol/l

1.79

194

Other diseases of liver

406

2.41

14.54

1.3

1.2

32.39

34.30

mmol/l

0.40

347

Hypothyroidism, strict autoimmune, 3 medication purchases required

366

1568

1.58

14.51

1.2

32.65

34.45

mmol/l

0.80

300

1339

Other mental disorders due to brain damage and dysfunction and to physical disease

289

2.69

14.51

1.2

1.1

32.25

34.69

mmol/l

0.35

238

Any event in cancer register

390

1470

1.57

14.48

1.3

1.2

34.28

33.42

mmol/l

0.29

343

1252

Type 2 diabetes, strict (exclude DM1)

400

1512

1.56

14.47

1.2

33.68

34.82

mmol/l

0.43

334

1293

Dorsopathies

431

1427

1.54

14.34

1.2

1.4

33.33

35.00

mmol/l

0.71

367

1249

Sequelae with surgical and medical care as external cause

114

515

2.23

14.33

1.4

1.1

28.68

35.61

mmol/l

2.99

440

Any dementia, excluding more controls

184

667

1.91

14.21

1.1

33.43

35.75

mmol/l

0.69

149

560

Glomerular diseases

101

436

2.33

14.14

1.3

1.2

29.19

36.80

mmol/l

3.55

377

Phobic anxiety disorders

168

3.23

14.14

1.6

1.7

35.28

35.76

mmol/l

0.04

157

Other (not insulin) diabetes medications

411

1589

1.54

14.13

1.2

32.91

34.75

mmol/l

0.87

347

1361

Acute pancreatitis

103

450

2.30

14.02

1.4

1.1

30.69

35.30

mmol/l

1.36

392

Disorders of gallbladder, biliary tract and pancreas

430

1793

1.52

14.00

1.5

1.2

33.12

34.80

mmol/l

0.77

358

1541

Major coronary heart disease event

382

1491

1.55

13.67

1.2

1.3

35.16

33.83

mmol/l

0.48

338

1267

Respiratory insufficiency

137

3.45

13.63

2.1

1.3

25.40

37.40

mmol/l

4.29

124

Disorders of choroid and retina

369

1696

1.55

13.62

1.1

1.2

32.52

34.69

mmol/l

1.09

312

1438

Disorders of eyelid, lacrimal system and orbit

375

1858

1.54

13.46

1.2

33.90

34.13

mmol/l

0.07

317

1590

Angina pectoris

270

1079

1.67

13.45

1.1

34.84

34.12

mmol/l

0.18

222

904

Nonorganic sleeping disorders

396

2.36

13.44

1.4

1.3

31.55

35.46

mmol/l

0.94

351

Functional dyspepsia

123

588

2.10

13.42

1.3

1.1

31.84

35.78

mmol/l

1.16

105

493

Chronic periodontitis, complicated

246

1453

1.68

13.42

1.1

1.2

30.13

34.81

mmol/l

3.29

215

1234

Benign neoplasms

395

1419

1.54

13.40

1.3

35.57

34.35

mmol/l

0.40

334

1232

Type 2 diabetes, definitions combined, including avohilmo

393

1494

1.53

13.39

1.2

33.56

34.89

mmol/l

0.52

329

1280

Other disorders of bladder

217

2.88

13.34

1.1

39.45

36.49

mmol/l

0.33

188

Dental caries, including avohilmo

338

1085

1.60

13.29

1.3

1.4

33.86

35.19

mmol/l

0.48

289

930

Use of disulfiram, acamprosate or naltrexone

155

3.26

13.25

1.3

1.2

30.53

37.10

mmol/l

1.07

142

Percutaneous Coronary Intervention

352

1381

1.57

13.25

1.2

1.3

35.75

33.69

mmol/l

0.81

313

1179

Symptoms and signs involving the skin and subcutaneous tissue

307

1900

1.59

13.16

1.3

1.2

34.53

34.24

mmol/l

0.07

260

1629

Myocardial infarction

239

986

1.71

13.07

1.2

1.1

36.44

33.71

mmol/l

0.87

201

818

ILD medications: azathioprine

293

2.58

13.06

1.7

1.3

28.71

36.02

mmol/l

1.51

257

Acute bronchitis

199

1105

1.77

13.03

1.7

1.3

35.23

34.80

mmol/l

0.09

165

940

Fracture of femur

160

768

1.90

12.91

1.3

1.2

33.12

34.63

mmol/l

0.35

133

640

Gingivitis and periodontal diseases

448

1558

1.49

12.83

1.2

1.3

33.98

34.89

mmol/l

0.33

383

1346

Other diseases of the respiratory system

113

534

2.13

12.75

1.6

1.2

29.66

35.39

mmol/l

1.92

453

Other respiratory disorders and diseases

113

534

2.13

12.75

1.6

1.2

29.66

35.39

mmol/l

1.92

453

Other disorders of glucose regulation and pancreatic internal secretion

185

3.00

12.73

1.7

1.3

29.86

36.09

mmol/l

1.27

169

Other diseases of intestine

291

2.56

12.73

2.3

1.2

35.57

35.51

mmol/l

0.01

248

Specific personality disorders

381

2.35

12.73

1.4

1.2

28.01

35.73

mmol/l

2.69

335

Azathioprine

298

2.53

12.63

1.7

1.3

28.71

35.39

mmol/l

1.33

263

Chronic gastritis

140

718

1.96

12.62

1.2

1.1

31.56

35.18

mmol/l

1.03

115

596

Coronary revascularization (ANGIO or CABG)

349

1381

1.55

12.61

1.2

1.3

35.49

33.69

mmol/l

0.67

310

1179

Other inflammatory liver diseases

130

3.42

12.61

1.4

1.2

30.05

34.29

mmol/l

0.71

115

Hernia

407

1830

1.49

12.58

1.4

1.2

34.33

33.99

mmol/l

0.11

354

1571

Systemic connective tissue disorders

175

968

1.82

12.49

1.3

1.2

32.06

34.22

mmol/l

0.66

151

801

Undetermined asthma

226

2.76

12.38

1.3

1.1

34.02

37.95

mmol/l

0.83

201

Other symptoms and signs involving the nervous and musculoskeletal systems

186

1057

1.77

12.12

1.3

1.2

33.80

34.91

mmol/l

0.24

165

900

Emergency coronary revascularization (for ACS)

388

1574

1.50

12.12

1.2

35.61

33.88

mmol/l

0.70

340

1333

Viral and other specified intestinal infections

392

2.28

12.10

2.6

1.6

34.84

36.67

mmol/l

0.27

348

Acute and transient psychotic disorders

218

2.77

12.09

1.1

1.2

28.85

36.64

mmol/l

2.19

194

Acute pancreatitis (for exclusion)

103

480

2.16

12.07

1.4

1.2

30.69

36.05

mmol/l

1.71

411

Streptococcal septicaemia

175

3.00

12.05

1.6

1.2

31.62

35.72

mmol/l

0.64

155

Peripheral arterial reconstruction

442

2.21

12.03

1.1

28.63

35.57

mmol/l

2.98

364

Somatoform disorder

306

2.47

11.97

1.4

1.2

34.52

34.25

mmol/l

0.04

263

Malignant neoplasm

360

1401

1.52

11.96

1.3

1.2

33.56

33.45

mmol/l

0.03

318

1192

Agranulocytosis

265

2.59

11.96

2.0

1.3

32.22

33.77

mmol/l

0.24

230

Colectomy operation

437

2.21

11.94

2.4

1.1

34.33

34.20

mmol/l

0.02

372

Collagenous colitis

203

2.84

11.94

1.9

1.2

33.22

34.95

mmol/l

0.18

177

Other diseases of anus and rectum

138

717

1.93

11.91

1.3

1.2

31.12

35.20

mmol/l

1.32

104

610

Lack of expected normal physiological development

5.49

11.89

4.8

4.7

30.02

40.56

mmol/l

1.15

Other diseases of hard tissues of teeth

266

838

1.65

11.88

1.3

1.2

33.22

35.29

mmol/l

0.74

226

731

Lung diseases due to external agents

350

2.36

11.87

1.4

1.1

33.13

35.35

mmol/l

0.41

298

Osteonecrosis

116

3.49

11.82

1.3

1.1

29.37

34.27

mmol/l

0.69

103

Assault

204

2.81

11.81

1.5

1.3

32.74

37.42

mmol/l

0.55

192

Injuries to the elbow and forearm

310

1768

1.54

11.77

1.4

1.3

33.30

34.17

mmol/l

0.28

252

1537

Budesonide

262

2.57

11.69

1.8

1.1

34.98

mmol/l

0.00

229

Other specified and unspecified personality disorders

133

3.26

11.47

1.7

1.2

27.08

37.66

mmol/l

2.14

124

Insulin, fast-acting (human)

259

2.56

11.44

1.1

1.2

28.04

36.01

mmol/l

2.61

231

Lung cancer and mesothelioma

333

2.27

11.41

1.2

1.1

34.98

37.80

mmol/l

0.55

285

Hypoglycaemia, other or unspecified

144

3.16

11.38

1.8

1.4

30.70

36.49

mmol/l

0.93

132

Asthma, including avohilmo

495

1965

1.42

11.33

1.3

1.4

30.94

35.03

mmol/l

3.87

415

1710

Malignant neoplasm of head and neck

171

2.95

11.28

1.3

1.2

29.80

35.23

mmol/l

1.15

149

Cardiomyopathy

377

2.27

11.27

1.3

1.2

36.15

36.04

mmol/l

0.01

314

Chronic apical periodontitis

456

1813

1.43

11.21

1.4

1.2

33.49

34.59

mmol/l

0.45

377

1564

Coagulation defects, purpura and other haemorrhagic conditions

462

2.13

11.19

1.9

1.2

34.26

34.86

mmol/l

0.08

403

Malignant neoplasm, wide definition for exclusion

362

1420

1.50

11.14

1.2

33.39

33.37

mmol/l

0.00

318

1210

Emotionally unstable personality disorder

146

3.10

11.10

1.7

1.2

28.38

36.77

mmol/l

1.80

131

Injury, poisoning and certain other consequences of external causes

213

624

1.71

11.02

1.3

1.5

32.83

35.84

mmol/l

1.17

190

555

Other disorders of lacrimal gland

158

882

1.80

11.01

1.3

1.2

31.56

34.28

mmol/l

0.96

134

746

Open wound of lower leg

350

2.30

10.97

1.3

31.99

35.14

mmol/l

0.61

301

Other intervertebral disc disorders

328

1300

1.52

10.95

1.2

31.94

34.88

mmol/l

1.73

277

1126

Liquid cancers, helper endpoint

186

945

1.72

10.94

1.2

33.53

34.59

mmol/l

0.28

165

785

Non-allergic asthma (mode), excluding more controls

341

2.30

10.89

1.3

34.92

36.59

mmol/l

0.26

298

Biguanides

398

1667

1.46

10.81

1.1

1.2

33.06

34.64

mmol/l

0.69

331

1429

Intracerebral haemorrhage

316

2.36

10.74

1.2

1.1

32.09

34.93

mmol/l

0.53

254

Speech disturbances, not elsewhere classified

204

2.72

10.72

1.2

36.46

33.90

mmol/l

0.30

176

Other systemic involvement of connective tissue (FG)

127

659

1.91

10.70

1.3

1.2

32.81

35.07

mmol/l

0.55

110

563

Other viral diseases, not elsewhere classified

417

2.16

10.67

2.2

1.5

36.76

36.04

mmol/l

0.09

375

Schizoaffective disorder

119

3.30

10.66

1.1

1.2

27.18

38.72

mmol/l

2.73

110

Pain associated with micturition

251

2.53

10.63

1.3

33.57

34.19

mmol/l

0.07

224

Injuries to the shoulder and upper arm

361

1987

1.47

10.61

1.3

1.2

31.85

34.61

mmol/l

1.58

305

1709

Other nutritional deficiencies

255

1533

1.57

10.56

1.2

1.3

31.39

34.60

mmol/l

1.46

211

1331

Benign neoplasm of colon, rectum, anus and anal canal

289

1646

1.53

10.50

1.2

1.1

32.75

34.62

mmol/l

0.65

249

1387

Migraine

180

850

1.72

10.47

1.4

1.5

34.51

35.08

mmol/l

0.11

153

738

Behavioural syndromes associated with physiological disturbances and physical factors

372

1813

1.46

10.40

1.3

31.29

34.51

mmol/l

1.95

313

1571

Elevated blood glucose level

186

2.77

10.28

1.5

1.2

30.30

34.91

mmol/l

0.69

169

Hepatic failure, not elsewhere classified

3.86

10.24

1.3

29.27

34.95

mmol/l

0.73

Congenital malformations, deformations and chromosomal abnormalities

217

1281

1.62

10.21

1.8

1.3

35.21

34.21

mmol/l

0.22

187

1115

Glomerular disorders in diseases classified elsewhere

269

2.44

10.15

1.1

1.2

28.45

34.71

mmol/l

1.91

234

Superficial injury of hip and thigh

356

2.23

10.13

1.3

1.2

34.79

33.56

mmol/l

0.17

293

Molar incisor enamel hypoplasia, with caries

5.05

10.08

1.6

3.0

26.83

42.87

mmol/l

1.93

Familial hypercholesterolemia

188

2.73

10.05

1.1

33.27

37.07

mmol/l

0.58

148

Other diseases of pancreas

183

2.76

10.02

1.3

1.1

26.97

33.31

mmol/l

1.20

158

Mental and behavioural disorders due to tobacco

161

2.88

10.00

1.4

1.2

27.50

37.28

mmol/l

2.98

146

Myalgia

101

504

2.01

9.95

1.2

32.64

34.78

mmol/l

0.42

430

Caries of dentine, including avohilmo

343

1183

1.48

9.89

1.2

1.4

34.49

35.12

mmol/l

0.19

292

1022

Sleep disorders (combined)

460

1725

1.40

9.86

1.3

1.2

32.22

34.68

mmol/l

1.52

389

1495

Migraine with aura

412

2.12

9.85

1.3

1.6

31.52

36.93

mmol/l

1.18

356

Abnormal findings on examination of blood, without diagnosis

205

1161

1.63

9.83

1.3

1.2

31.94

35.39

mmol/l

1.15

176

986

Smoking dependency

163

2.85

9.79

1.4

1.2

27.50

37.21

mmol/l

2.96

147

Benign neoplasm: Stomach

238

2.50

9.75

1.2

1.1

32.81

34.73

mmol/l

0.23

202

Vitamin B12 deficiency anaemia

244

2.48

9.74

1.6

1.1

30.79

34.10

mmol/l

0.42

199

Alzheimer’s disease (Late onset), excluding more controls

221

2.30

9.66

1.1

33.97

37.27

mmol/l

0.59

184

Disturbances of skin sensation

113

593

1.91

9.64

1.4

1.2

36.95

34.77

mmol/l

0.34

508

Diagnoses used for exclusion with ILD

121

652

1.86

9.53

1.3

1.2

32.05

35.40

mmol/l

0.98

101

551

Disorders of continuity of bone

171

2.77

9.53

1.5

1.2

37.34

36.42

mmol/l

0.08

150

Vitamin deficiency

3.48

9.48

1.4

1.2

27.92

36.05

mmol/l

1.12

Vitamin deficiency, wide

3.48

9.48

1.4

1.2

27.92

36.05

mmol/l

1.12

Suppurative and necrotic conditions of lower respiratory tract

113

3.22

9.46

1.6

1.2

36.84

34.79

mmol/l

0.18

102

Diaphragmatic hernia

172

1030

1.68

9.42

1.3

1.2

34.83

34.54

mmol/l

0.06

150

865

Amputation

236

2.48

9.41

1.3

1.2

33.24

35.11

mmol/l

0.29

203

Lichen simplex chronicus and prurigo

129

3.05

9.39

1.1

1.2

24.50

35.56

mmol/l

3.21

113

Diabetic maculopathy, excluding more controls

213

2.55

9.35

1.1

28.03

35.50

mmol/l

2.15

186

Asthma, hospital admissions , main diagnosis only

336

2056

1.44

9.32

1.3

1.4

32.04

34.56

mmol/l

1.36

282

1779

Cervicalgia

442

2.05

9.30

1.2

34.04

36.17

mmol/l

0.41

378

Other diseases of lip and oral mucosa

170

1019

1.67

9.28

1.2

31.49

35.17

mmol/l

1.48

141

878

Endovascular or surgical operations to intracerebral aneurysms

125

3.07

9.24

1.3

1.1

27.47

33.94

mmol/l

1.33

109

Later onset COPD

144

652

1.77

9.19

1.1

32.99

35.83

mmol/l

0.87

119

534

Diseases of pulp and periapical tissues and dental caries

287

972

1.52

9.19

1.3

33.29

35.54

mmol/l

0.98

246

829

Unknown and unspecified causes of morbidity

3.47

9.18

1.5

1.2

32.35

35.68

mmol/l

0.41

Acute upper respiratory infections of multiple and unspecified sites

297

1489

1.48

9.14

1.3

32.89

34.47

mmol/l

0.53

250

1288

Myocardial infarction, without ST-elevation

193

1090

1.62

9.12

1.2

1.1

37.44

34.62

mmol/l

0.73

163

905

Benign neoplasm of other and ill-defined parts of digestive system

460

2.01

9.08

1.3

1.1

32.33

34.76

mmol/l

0.44

388

Non-allergic asthma (mode)

369

2.13

9.07

1.3

34.92

36.99

mmol/l

0.34

323

Pain in joint

216

866

1.59

9.03

1.5

1.3

33.66

36.05

mmol/l

0.79

178

764

Fracture of forearm

243

1460

1.53

8.98

1.3

1.2

32.12

33.99

mmol/l

0.76

205

1261

Inflammatory diseases of the central nervous system

171

2.71

8.98

1.3

1.2

37.41

34.55

mmol/l

0.26

155

Disorders of lacrimal system

187

1156

1.62

8.96

1.2

31.29

34.26

mmol/l

1.27

159

978

Abnormal weight loss

218

2.50

8.94

1.4

1.3

27.52

35.53

mmol/l

2.19

187

Visual disturbances and blindness

225

1460

1.54

8.85

1.3

32.12

34.87

mmol/l

1.02

191

1243

Endocarditis

4.05

8.80

1.5

1.3

42.21

31.62

mmol/l

0.95

Other diseases of blood and blood-forming organs

145

2.86

8.80

1.1

28.77

33.76

mmol/l

0.84

128

Other systemic involvement of connective tissue

130

735

1.78

8.80

1.3

1.1

32.52

34.56

mmol/l

0.50

113

607

Diabetic nephropathy, excluding more controls

280

2.19

8.77

1.1

1.2

28.38

35.95

mmol/l

2.71

235

Benign neoplasm: Colon

242

1527

1.52

8.71

1.2

1.1

34.01

34.52

mmol/l

0.12

212

1282

Weight loss

239

2.40

8.71

1.5

1.3

27.04

35.84

mmol/l

2.72

204

Focal brain injury

104

3.20

8.62

1.1

36.99

35.95

mmol/l

0.05

Drug-induced neutropenia

147

2.82

8.59

1.1

1.2

34.87

34.17

mmol/l

0.07

129

Other viral diseases

116

637

1.82

8.56

2.0

1.6

34.60

35.45

mmol/l

0.12

104

562

Dipeptidyl peptidase 4 (DPP-4) inhibitors

247

1311

1.51

8.55

1.1

31.92

34.82

mmol/l

1.35

211

1110

Visual disturbances

206

1322

1.56

8.55

1.3

1.2

32.66

34.97

mmol/l

0.73

175

1127

Migraine without aura

278

2.27

8.55

1.5

1.6

37.44

34.93

mmol/l

0.32

250

Eating disorders

147

2.80

8.54

2.3

1.5

27.77

34.91

mmol/l

1.20

140

Fracture of lower leg, including ankle

231

1505

1.52

8.53

1.3

1.2

30.33

34.44

mmol/l

2.02

177

1302

Obesity related asthma

139

810

1.72

8.47

1.2

30.35

35.62

mmol/l

2.40

114

703

Purpura and other haemorrhagic conditions

312

2.19

8.43

2.0

1.3

34.76

35.08

mmol/l

0.03

272

Diseases of oral cavity, salivary glands and jaws

252

850

1.53

8.43

1.3

1.2

34.42

35.40

mmol/l

0.28

211

739

Alzheimer disease, excluding more controls

254

2.11

8.41

1.1

35.09

37.62

mmol/l

0.41

211

Fentanyl

225

2.41

8.34

1.7

1.1

35.03

33.89

mmol/l

0.14

182

Other and unspecified injuries of head

139

2.83

8.27

1.2

1.3

39.44

36.25

mmol/l

0.32

122

Traumatic subarachnoid haemorrhage

3.85

8.25

1.2

1.1

29.33

34.53

mmol/l

0.46

Unstable angina pectoris

175

853

1.62

8.24

1.2

1.1

35.52

34.09

mmol/l

0.30

138

703

Solid cancers, helper endpoint

332

1374

1.43

8.22

1.2

33.18

33.55

mmol/l

0.11

290

1165

Mixed and other personality disorders

102

3.16

8.22

1.3

1.1

25.21

38.00

mmol/l

2.87

Diseases of pulp and periapical tissues, including avohilmo

432

1634

1.37

8.22

1.4

1.3

33.77

35.27

mmol/l

0.64

365

1416

Dental operations

266

912

1.50

8.21

1.2

33.57

35.56

mmol/l

0.77

223

789

Calcific aortic valvular stenosis

150

873

1.67

8.18

1.1

35.17

35.12

mmol/l

0.01

126

720

Calcific aortic valvular stenosis, operated

150

873

1.67

8.18

1.1

35.17

35.12

mmol/l

0.01

126

720

Injuries to the knee and lower leg

476

1965

1.35

8.16

1.3

31.99

34.67

mmol/l

1.74

392

1709

Excessive attrition of teeth

201

1298

1.55

8.14

1.3

1.2

31.56

34.88

mmol/l

1.27

177

1128

Myocardial infarction, strict

204

932

1.56

8.06

1.2

1.1

35.90

33.83

mmol/l

0.56

175

772

Deforming dorsopathies

116

652

1.79

8.04

1.1

1.3

31.55

35.81

mmol/l

1.29

568

Fall on same level involving ice and snow

235

1575

1.50

8.01

1.3

1.2

34.71

34.28

mmol/l

0.11

204

1338

Other disorders of ear

381

1807

1.38

7.98

1.3

32.41

34.77

mmol/l

1.37

331

1549

Congenital malformations, deformations and chromosomal abnormalities

229

1404

1.51

7.97

1.3

35.28

34.29

mmol/l

0.23

196

1221

Calcific aortic valvular stenosis, including rheumatic fever

149

871

1.66

7.97

1.1

34.92

35.29

mmol/l

0.07

125

718

Sleep disorders

338

1741

1.40

7.91

1.2

31.08

34.20

mmol/l

1.92

288

1506

Irritable bowel syndrome

101

548

1.85

7.87

1.4

1.2

32.09

34.73

mmol/l

0.50

466

Calcific aortic valvular stenosis, diagnosis (helper)

148

868

1.66

7.85

1.1

34.97

35.14

mmol/l

0.03

124

715

Operations 2 for CAVS

148

868

1.66

7.85

1.1

34.97

35.14

mmol/l

0.03

124

715

Benign neoplasm: Colon, unspecified

118

672

1.76

7.85

1.2

1.1

32.82

34.99

mmol/l

0.48

102

563

Malignant neoplasm of oral cavity

3.52

7.83

1.2

30.33

34.61

mmol/l

0.51

Symptoms and signs involving speech and voice

143

859

1.67

7.83

1.2

35.37

34.87

mmol/l

0.08

115

730

Prurigo nodularis

4.11

7.83

1.1

1.2

25.56

36.99

mmol/l

1.52

Sequelae of injuries of head

3.25

7.80

1.3

1.1

42.21

35.41

mmol/l

0.40

Abnormalities of gait and mobility

303

2.16

7.79

1.3

32.51

33.81

mmol/l

0.19

261

Other viral diseases, not elsewhere classified

104

568

1.83

7.79

2.1

1.7

37.07

35.64

mmol/l

0.20

503

Any dementia

196

874

1.56

7.73

1.1

33.40

35.22

mmol/l

0.53

156

724

Malignant neoplasm of tongue, including Hilmo

3.92

7.73

1.1

1.2

31.69

34.27

mmol/l

0.22

Peripheral artery operations in Hilmo

300

2.14

7.56

1.2

28.27

36.22

mmol/l

3.17

247

Injuries to the ankle and foot

255

1559

1.46

7.52

1.3

1.4

33.51

34.66

mmol/l

0.32

218

1361

Other symptoms and signs involving the digestive system and abdomen

361

2.03

7.50

1.9

1.2

30.15

34.37

mmol/l

0.81

305

Cerebral palsy and other paralytic syndromes

257

2.23

7.43

3.4

1.3

38.84

35.14

mmol/l

0.46

230

Duodenal ulcer

238

2.28

7.42

1.2

1.1

35.06

35.39

mmol/l

0.04

206

Other symptoms and signs involving general sensations and perceptions

3.29

7.39

1.1

1.4

33.39

35.48

mmol/l

0.15

Finngen Rheumatological endpoints

355

1460

1.38

7.37

1.2

1.3

33.39

34.79

mmol/l

0.52

309

1275

Persons with potential health hazards related to communicable diseases

129

760

1.69

7.36

1.7

1.6

34.78

34.53

mmol/l

0.04

116

677

Sequelae of injuries, of poisoning and of other consequences of external causes

518

1.84

7.32

1.3

1.2

35.16

35.54

mmol/l

0.04

456

Lumbar disc prolapse

236

1228

1.48

7.32

1.3

1.2

32.52

34.97

mmol/l

1.03

203

1070

Malignant neoplasm of oral cavity, including Hilmo

3.12

7.29

1.3

1.1

29.13

34.04

mmol/l

0.69

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

197

1263

1.52

7.25

1.3

1.2

34.13

35.19

mmol/l

0.28

167

1092

Venous thromboembolism

231

1522

1.47

7.23

1.2

1.1

33.78

35.14

mmol/l

0.35

197

1278

Erosion of teeth , including avohilmo

485

1.86

7.20

1.5

1.3

31.57

35.21

mmol/l

0.74

424

Other symptoms and signs involving the urinary system

217

2.32

7.14

1.2

32.78

35.16

mmol/l

0.32

195

Persistent delusional disorders

157

2.57

7.09

1.2

1.1

20.39

34.18

mmol/l

4.25

136

Disorders of ocular muscles, binocular movement, accommodation and refraction

176

1131

1.55

7.07

2.0

1.4

34.00

34.88

mmol/l

0.17

152

987

Diseases of the musculoskeletal system and connective tissue

208

683

1.53

7.06

1.4

1.6

34.13

35.68

mmol/l

0.40

190

616

All influenza (not pneumonia)

289

2.12

7.04

1.4

1.2

33.84

36.53

mmol/l

0.38

260

Cervical disc disorders

142

877

1.62

7.03

1.3

1.1

34.15

35.21

mmol/l

0.21

117

754

Persistent mood disorders

385

1.96

6.97

1.4

1.2

31.06

36.20

mmol/l

1.18

331

Reimbursement for rheumatic diseases

233

1599

1.45

6.96

1.3

1.2

32.00

34.34

mmol/l

0.93

193

1369

Glomerulonephritis

226

2.27

6.95

1.4

1.3

27.70

35.13

mmol/l

1.99

201

Disorders of parathyroid gland

104

586

1.76

6.93

1.2

1.1

32.89

33.64

mmol/l

0.12

477

Transport accidents

150

806

1.60

6.92

1.3

1.4

35.88

35.38

mmol/l

0.08

133

718

Blepharochalasis

137

844

1.63

6.87

1.1

1.2

33.85

34.59

mmol/l

0.16

112

706

Other disorders of eyelid

198

1262

1.50

6.82

1.1

1.2

34.55

34.40

mmol/l

0.03

167

1056

Other congenital malformations of intestine

7.43

6.78

8.3

2.1

48.00

27.38

mmol/l

1.66

Dementia

206

949

1.50

6.76

1.1

32.67

35.28

mmol/l

0.92

166

788

Dementia, including avohilmo

218

1017

1.48

6.70

1.1

32.44

35.25

mmol/l

1.07

174

840

Hydronephrosis

243

2.19

6.67

1.4

1.2

33.18

35.98

mmol/l

0.39

204

Enlarged lymph nodes

243

2.19

6.66

1.4

32.23

35.71

mmol/l

0.54

214

Allergic asthma (mode), excluding more controls

343

1.97

6.59

1.5

1.3

29.45

35.80

mmol/l

1.37

307

Disorders of refraction and accommodation

103

593

1.74

6.57

2.6

1.6

33.50

35.00

mmol/l

0.23

530

Other congenital malformations of intestine

6.35

6.53

7.9

1.9

46.25

30.19

mmol/l

1.24

Presence of cardiac and vascular implants and grafts

194

964

1.50

6.51

1.2

1.1

34.14

35.30

mmol/l

0.29

166

818

Conductive and sensorineural hearing loss

329

1631

1.36

6.46

1.4

1.2

31.94

34.71

mmol/l

1.68

280

1387

177

2.39

6.44

1.2

1.1

30.83

35.62

mmol/l

0.73

150

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

390

1.90

6.44

1.6

1.9

32.95

35.71

mmol/l

0.43

352

Monoamine oxidase A inhibitors

215

2.24

6.40

1.1

31.70

35.31

mmol/l

0.56

188

Other and unspecified local infections of skin and subcutaneous tissue

209

2.26

6.39

2.2

1.3

41.15

33.93

mmol/l

0.72

185

Other viral diseases

130

800

1.62

6.36

1.9

1.6

35.25

35.40

mmol/l

0.02

118

709

Degenerative diseases of the nervous system

177

858

1.52

6.33

1.1

32.72

35.35

mmol/l

0.79

138

712

5-aminosalicylic acid

420

1.86

6.32

1.9

1.2

34.96

34.85

mmol/l

0.01

371

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

421

1.85

6.31

1.6

1.9

33.16

36.04

mmol/l

0.47

378

Parkinson's disease, excluding more controls

234

2.14

6.27

1.1

31.63

37.54

mmol/l

1.49

198

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

369

1774

1.33

6.25

1.2

34.37

34.41

mmol/l

0.01

322

1509

Pulmonary heart disease, diseases of pulmonary circulation

145

929

1.57

6.21

1.2

32.97

35.49

mmol/l

0.60

126

777

Other disorders of skin and subcutaneous tissue, not elsewhere classified

339

1.96

6.18

1.7

1.1

32.41

35.12

mmol/l

0.43

291

Obesity and other hyperalimentation

219

1472

1.44

6.16

1.1

1.2

31.42

34.49

mmol/l

1.34

180

1276

Asthma and allergy, excluding more controls

172

2.36

6.15

1.7

1.6

26.16

35.88

mmol/l

2.32

158

Other necrotizing vasculopathies (FG)

133

2.58

6.12

1.1

1.2

31.88

35.07

mmol/l

0.38

114

Decubitus ulcer and pressure area

139

2.54

6.11

1.4

1.2

28.92

34.81

mmol/l

1.28

120

Complications of internal orthopaedic prosthetic devices, implants and grafts

105

625

1.69

6.08

1.3

1.1

32.71

35.57

mmol/l

0.73

524

Insomnia

315

1696

1.35

6.06

1.2

31.09

34.20

mmol/l

1.79

269

1469

Sensorineural hearing loss

314

1573

1.36

6.04

1.4

1.2

31.30

34.82

mmol/l

2.51

270

1335

Fissure and fistula of anal and rectal regions

492

1.77

6.03

1.5

1.2

35.15

35.28

mmol/l

0.01

419

Soft tissue disorders

398

1555

1.32

6.03

1.3

1.4

35.37

34.25

mmol/l

0.38

348

1354

Obesity

217

1465

1.43

6.02

1.1

1.2

31.30

34.45

mmol/l

1.39

178

1269

Misadventures to patients during surgical and medical care

308

1.99

6.01

1.4

1.2

37.34

35.17

mmol/l

0.28

267

Adjustment and management of implanted device

472

1.79

5.97

2.2

1.1

36.70

35.73

mmol/l

0.14

381

Rheumatoid arthritis

135

768

1.58

5.96

1.2

1.1

32.20

34.26

mmol/l

0.54

107

653

Diabetic retinopathy, strict definition

383

1.83

5.94

1.2

26.90

34.48

mmol/l

3.34

324

Tubulo-interstitial nephritis, not specified as acute or chronic

142

2.48

5.86

1.3

1.1

27.01

34.99

mmol/l

1.92

126

Other disorders of kidney and ureter

325

1.95

5.85

1.3

1.2

26.88

34.20

mmol/l

1.92

282

Other diseases of upper respiratory tract

443

1788

1.29

5.82

1.3

1.4

33.56

34.66

mmol/l

0.45

372

1542

Pyogenic arthritis

131

2.54

5.78

1.7

1.2

35.99

36.40

mmol/l

0.02

111

Lesion of ulnar nerve

293

1.99

5.72

1.2

29.67

35.19

mmol/l

1.53

260

Asthma and allergy

178

2.28

5.72

1.7

1.5

26.16

36.11

mmol/l

2.43

164

Migraine with aura and triptan purchases

239

2.10

5.71

1.4

29.40

34.29

mmol/l

0.74

211

Degeneration of macula and posterior pole

215

1203

1.43

5.69

1.1

32.93

34.95

mmol/l

0.66

174

1006

Disease of hard tissues of teeth, NOS

216

784

1.44

5.69

1.2

34.34

35.60

mmol/l

0.32

185

685

Ventral hernia

102

614

1.67

5.68

1.7

1.1

33.58

34.76

mmol/l

0.20

518

Other necrotizing vasculopathies

169

2.33

5.67

1.2

32.75

35.72

mmol/l

0.39

146

Pruritus

240

2.09

5.67

1.0

1.2

24.77

35.27

mmol/l

3.65

210

Migraine without aura and triptan purchases

227

2.12

5.64

1.5

36.62

34.52

mmol/l

0.25

206

Allergic asthma (mode)

363

1.86

5.64

1.5

1.4

29.45

36.09

mmol/l

1.47

327

Vascular dementia

251

2.05

5.63

1.1

34.36

35.77

mmol/l

0.19

200

Right hemicolectomy

139

2.47

5.62

1.4

1.2

36.53

35.44

mmol/l

0.09

121

Stomatitis and related lesions

453

1.77

5.56

1.5

1.3

32.82

34.93

mmol/l

0.35

392

L01XE Protein kinase inhibitors

128

2.52

5.54

1.2

36.11

33.91

mmol/l

0.20

113

Other local infections of skin and subcutaneous tissue

229

2.11

5.54

2.2

1.3

41.94

34.03

mmol/l

0.84

204

Assault by bodily force

122

2.55

5.53

1.1

1.2

36.95

36.16

mmol/l

0.04

117

Hernia of abdominal wall

176

1207

1.46

5.52

1.6

1.2

33.61

35.18

mmol/l

0.39

153

1020

Recurrent aphthous stomatitis , including avohilmo

332

1.91

5.51

1.6

1.2

33.29

35.77

mmol/l

0.35

291

Faecal incontinence

223

2.12

5.50

1.5

1.1

31.29

34.82

mmol/l

0.65

186

Chronic sinusitis

155

1036

1.50

5.50

1.3

1.2

35.86

35.29

mmol/l

0.11

132

888

Disorders of skin appendages

166

1125

1.48

5.49

1.2

1.4

29.46

35.52

mmol/l

3.14

134

984

Myeloproliferative diseases

191

2.21

5.47

1.1

1.2

34.66

33.47

mmol/l

0.13

164

Acute upper respiratory infections

404

1929

1.29

5.47

1.3

33.31

34.35

mmol/l

0.38

339

1662

Disorders of optic nerve and visual pathways

191

2.21

5.46

1.7

1.3

40.91

35.07

mmol/l

0.66

174

Soft tissue disorders related to use, overuse and pressure

109

676

1.62

5.42

1.2

34.46

34.92

mmol/l

0.07

579

Diabetic nephropathy

415

1.79

5.40

1.1

28.17

34.60

mmol/l

2.31

344

Viral infections characterized by skin and mucous membrane lesions

326

2116

1.32

5.40

1.3

33.34

34.36

mmol/l

0.32

279

1828

Exposure to other specified factors

273

1858

1.35

5.38

1.3

1.4

34.98

34.23

mmol/l

0.19

226

1620

Papulosquamous disorders

149

995

1.50

5.35

1.2

35.09

34.83

mmol/l

0.04

126

859

Inflammatory bowel disease

113

710

1.60

5.33

1.9

1.2

35.75

35.12

mmol/l

0.08

617

Other and unspecified effects of external causes

100

610

1.64

5.32

1.9

1.4

33.96

34.82

mmol/l

0.13

540

Other shoulder lesions

168

2.27

5.29

1.1

1.2

26.39

34.11

mmol/l

1.70

146

Diabetic neuropathy

294

1.94

5.26

1.3

1.2

27.03

35.11

mmol/l

2.72

245

Other infectious diseases

201

2.15

5.24

1.5

1.2

36.16

34.52

mmol/l

0.16

179

Hypoplasia of dental enamel, prenatal

6.43

5.23

2.3

3.3

26.00

33.54

mmol/l

0.45

Fall involving bed

2.78

5.22

1.8

1.4

33.57

33.77

mmol/l

0.01

DVT of lower extremities and pulmonary embolism

176

1216

1.44

5.21

1.2

33.13

35.33

mmol/l

0.60

153

1014

Hypoplasia of dental enamel, prenatal , including avohilmo

5.56

5.21

2.6

3.1

29.36

33.70

mmol/l

0.22

Trochanteric bursitis

340

1.86

5.16

1.3

1.2

36.09

34.69

mmol/l

0.17

286

Sicca syndrome [Sjögren]

196

2.16

5.15

1.1

30.39

33.93

mmol/l

0.61

168

Hyperplasia of prostate

132

482

1.56

5.13

1.1

34.21

36.72

mmol/l

0.65

118

420

Bell's palsy

250

2.01

5.12

1.2

37.02

35.28

mmol/l

0.23

225

Parkinson's disease, strict definition, excluding more controls

225

2.04

5.08

1.1

32.53

37.46

mmol/l

1.07

191

Gout

117

658

1.57

5.07

1.1

34.31

34.58

mmol/l

0.04

104

553

Chronic rhinitis, nasopharyngitis and pharyngitis

115

735

1.57

5.07

1.4

1.2

30.84

35.73

mmol/l

1.53

640

Obesity due to excess calories

155

1056

1.47

5.06

1.1

1.3

30.24

35.03

mmol/l

2.16

126

923

Diabetic retinopathy, excluding more controls

109

377

1.63

5.03

1.1

1.3

30.45

34.59

mmol/l

1.28

319

Sleep apnoea, including avohilmo

366

1757

1.29

5.00

1.3

1.2

33.45

34.13

mmol/l

0.22

310

1515

Ulcerative colitis

529

1.67

4.98

1.7

1.2

31.76

34.48

mmol/l

0.50

458

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

607

1.62

4.94

1.1

38.19

34.10

mmol/l

1.07

505

Coronary artery bypass grafting

111

523

1.59

4.91

1.1

30.59

34.91

mmol/l

1.40

426

Other and unspecified psoriasis

136

2.37

4.90

1.2

26.67

34.66

mmol/l

1.15

125

142

831

1.49

4.90

1.1

31.50

35.60

mmol/l

1.75

114

679

Acute sinusitis

170

1098

1.44

4.87

1.4

1.2

34.66

34.80

mmol/l

0.03

143

957

Congenital malformations of the circulatory system

357

1.80

4.86

1.6

1.9

34.67

35.60

mmol/l

0.11

328

Other disorders of eye and adnexa

304

1.88

4.86

1.5

1.2

35.19

35.42

mmol/l

0.03

267

Unspecified urinary incontinence

208

2.08

4.84

1.1

1.2

28.85

33.76

mmol/l

1.29

181

Extrapyramidal and movement disorders

156

1075

1.45

4.84

1.2

32.79

34.75

mmol/l

0.58

134

894

Pulmonary heart disease

126

832

1.52

4.82

1.2

1.1

32.29

35.28

mmol/l

0.73

109

689

Pulmonary embolism

126

833

1.52

4.79

1.2

1.1

32.29

35.24

mmol/l

0.71

109

690

Diseases of peritoneum

229

2.02

4.79

1.6

1.2

32.39

34.89

mmol/l

0.27

200

Other diseases of biliary tract

209

2.07

4.78

1.5

1.2

31.17

33.79

mmol/l

0.39

182

Cerebral aneurysm, nonruptured

183

2.14

4.75

1.2

26.79

35.00

mmol/l

2.63

158

Speech therapy

110

708

1.56

4.74

1.8

1.2

33.64

35.23

mmol/l

0.32

600

Congenital absence, atresia and stenosis of small intestine

16.21

4.74

7.3

3.0

48.14

25.20

mmol/l

—

Excessive earwax

218

1559

1.37

4.74

1.3

1.2

31.65

34.97

mmol/l

1.57

191

1321

Certain disorders involving the immune mechanism

461

1.70

4.73

1.5

1.3

27.59

35.80

mmol/l

3.27

401

Digestive system disorders of fetus and newborn

11.86

4.73

6.6

3.0

40.88

28.75

mmol/l

—

Superficial injury of abdomen, lower back and pelvis

322

1.84

4.70

1.6

1.3

33.98

35.58

mmol/l

0.17

283

Sleep apnoea

344

1731

1.29

4.67

1.3

1.2

32.37

34.35

mmol/l

0.90

292

1495

Special screening examination for other diseases and disorders

191

2.10

4.65

1.2

30.02

36.41

mmol/l

1.18

169

Hepatomegaly and splenomegaly, not elsewhere classified

6.26

4.63

1.1

1.4

32.90

34.00

mmol/l

0.06

Fibromyalgia

146

2.27

4.63

1.4

1.1

33.22

34.26

mmol/l

0.10

124

Vasomotor and allergic rhinitis

128

840

1.50

4.62

1.5

1.6

31.92

35.70

mmol/l

1.04

107

745

Diseases of salivary glands

120

793

1.52

4.60

1.2

35.91

34.96

mmol/l

0.16

104

683

Gout, FINNGEN

117

767

1.53

4.60

1.1

34.31

35.68

mmol/l

0.27

104

633

Fracture of foot, except ankle

534

1.63

4.58

1.2

30.25

34.53

mmol/l

1.08

465

Hallux valgus (acquired)

138

670

1.48

4.54

1.1

29.58

34.03

mmol/l

1.66

109

575

Disorders of sclera, cornea, iris and ciliary body

197

1435

1.38

4.49

1.2

33.41

34.74

mmol/l

0.39

176

1217

Statin medication

230

952

1.36

4.48

1.2

33.29

34.31

mmol/l

0.28

201

825

Fitting and adjustment of other devices

144

898

1.45

4.39

1.2

1.1

30.62

35.18

mmol/l

2.12

124

741

Other infectious diseases

170

2.13

4.34

1.6

1.2

35.25

mmol/l

0.00

153

Thyrotoxicosis, other and/or unspecified

450

1.67

4.34

1.2

32.77

33.48

mmol/l

0.10

383

Other arthritis (FG)

113

749

1.51

4.30

1.2

34.44

35.84

mmol/l

0.24

644

Contact with and exposure to communicable diseases

557

1.59

4.27

1.6

35.86

34.77

mmol/l

0.16

500

Alzheimer’s disease (Atypical or mixed), excluding more controls

134

2.15

4.26

1.0

1.1

31.12

36.82

mmol/l

0.86

110

Acute suppurative otitis media

443

1.65

4.23

2.4

1.9

29.14

36.94

mmol/l

2.37

407

Primary_lymphoid and hematopoietic malignant neoplasms

104

680

1.53

4.23

1.3

1.2

34.63

34.98

mmol/l

0.06

575

Overexertion and strenuous or repetitive movements

192

2.04

4.23

1.8

1.2

43.51

35.53

mmol/l

0.91

175

Ulcer of oesophagus

146

2.21

4.21

1.1

42.31

33.80

mmol/l

0.57

130

Diseases of male genital organs

180

647

1.41

4.21

1.3

1.4

37.28

35.95

mmol/l

0.25

161

578

Actinic keratosis

169

1123

1.40

4.20

1.1

38.81

33.94

mmol/l

1.66

138

932

Mucosal proctocolitis

234

1.93

4.19

1.6

1.2

36.98

34.57

mmol/l

0.24

212

Viral infections characterized by skin and mucous membrane lesions

160

1141

1.40

4.15

1.3

33.40

35.06

mmol/l

0.40

144

971

180

1202

1.38

4.10

1.1

38.41

33.87

mmol/l

1.60

146

999

Pemphigoid

2.89

4.07

1.1

1.2

41.75

33.23

mmol/l

0.61

Glaucoma

232

1511

1.32

4.07

1.1

1.2

31.50

34.81

mmol/l

1.65

203

1267

Unspecified privation

244

1.89

4.05

1.6

1.3

25.32

34.80

mmol/l

2.88

214

Polycystic ovarian syndrome, consortium definition

249

1121

1.32

4.01

1.5

1.2

31.43

33.25

mmol/l

0.65

206

957

Other respiratory diseases principally affecting the interstitium

476

1.62

4.00

1.3

1.1

33.00

34.69

mmol/l

0.32

392

Other specific joint derangements/joint disorders

249

1229

1.31

3.94

1.5

1.3

33.22

35.00

mmol/l

0.61

209

1078

Abnormal involuntary movements

305

1.78

3.91

2.1

1.2

31.99

33.43

mmol/l

0.18

264

Malignant neoplasm of urinary organs

226

1.91

3.91

1.1

37.27

34.63

mmol/l

0.27

190

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

303

1.74

3.89

2.1

2.5

37.68

34.64

mmol/l

0.38

290

Superficial injury of forearm

178

2.03

3.88

1.9

1.3

33.67

35.96

mmol/l

0.14

162

Visual field defects

185

2.01

3.88

1.8

1.2

35.23

35.68

mmol/l

0.04

159

Conduction disorders

109

592

1.50

3.87

1.2

35.56

34.55

mmol/l

0.18

495

Disorders of conjunctiva

299

1892

1.27

3.84

1.2

1.3

32.45

34.11

mmol/l

0.68

255

1634

Skin changes due to chronic exposure to nonionizing radiation

170

1147

1.37

3.81

1.1

38.78

33.91

mmol/l

1.68

139

952

Amputation of toe

166

2.06

3.80

1.3

1.1

28.26

34.36

mmol/l

1.48

144

Psoriasis

102

682

1.50

3.78

1.3

1.2

32.72

35.35

mmol/l

0.57

591

Injuries to unspecified part of trunk, limb or body region

229

1.89

3.77

1.5

1.3

32.61

34.82

mmol/l

0.21

201

Other specified/unspecified arthritis

100

668

1.50

3.73

1.2

35.51

35.66

mmol/l

0.02

578

Open wound of ankle and foot

223

1.89

3.72

1.3

1.2

34.38

35.33

mmol/l

0.10

201

Infections with a predominantly sexual mode of transmission

501

1.58

3.69

1.3

31.76

35.68

mmol/l

0.88

438

Pre-eclampsia or poor fetal growth

469

1.60

3.69

1.3

28.16

33.81

mmol/l

1.97

406

Injury of other and unspecified intrathoracic organs

122

2.23

3.67

1.4

1.1

40.38

35.82

mmol/l

0.30

108

IBD patients in KELA-register

449

1.61

3.64

1.8

1.2

37.19

34.58

mmol/l

0.30

394

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

113

774

1.46

3.63

1.4

1.5

33.78

35.73

mmol/l

0.37

687

Diplopia

313

1.73

3.61

1.2

29.78

35.85

mmol/l

1.26

273

Other (seronegative) rheumatoid arthritis, wide

498

1.57

3.59

1.1

32.29

34.31

mmol/l

0.40

418

Unspecified acute lower respiratory infection

329

1.71

3.57

1.3

34.86

35.15

mmol/l

0.03

289

Seropositive rheumatoid arthritis

656

1.49

3.57

1.2

32.52

35.15

mmol/l

0.59

561

Diseases of the ear and mastoid process

415

1707

1.22

3.53

1.3

32.75

34.86

mmol/l

1.18

363

1471

Obesity, other/unspecified

104

709

1.47

3.53

1.1

1.2

32.56

35.31

mmol/l

0.61

620

Fibroblastic disorders

580

1.52

3.52

1.2

1.1

40.22

35.36

mmol/l

1.22

488

Benign neoplasm of mouth and pharynx

242

1.83

3.51

1.3

1.2

38.62

34.72

mmol/l

0.41

210

Thyroiditis, ILD-related definition

242

1.83

3.51

1.1

1.2

29.51

35.00

mmol/l

1.02

215

Carcinoma in situ of skin of other and unspecified parts of face

235

1.84

3.51

1.1

1.2

34.49

34.34

mmol/l

0.01

195

Other/unspecified rheumatoid arthritis

316

1.72

3.50

1.1

1.2

30.65

34.39

mmol/l

0.84

265

Infections with a predominantly sexual mode of transmission

100

630

1.48

3.49

1.3

31.18

34.94

mmol/l

1.01

553

Seropositive rheumatoid arthritis, strict definition

362

1.66

3.48

1.2

1.1

31.86

33.98

mmol/l

0.32

311

Diabetic maculopathy

298

1.71

3.46

1.1

1.2

28.03

34.56

mmol/l

1.87

252

Unspecified dementia

284

1.72

3.46

1.1

30.90

35.17

mmol/l

0.79

228

Isolated growth hormone deficiency

3.65

3.45

6.2

2.2

27.25

37.16

mmol/l

0.87

Status post-ami

104

539

1.47

3.45

1.1

34.48

34.80

mmol/l

0.05

443

Rash and other nonspecific skin eruption

215

1.87

3.44

1.6

1.3

35.49

34.68

mmol/l

0.08

186

Diabetic retinopathy

144

645

1.40

3.43

1.1

1.2

29.96

33.90

mmol/l

1.52

123

551

Heartburn

201

1.90

3.42

1.2

29.93

36.15

mmol/l

1.06

172

Unspecific neurodegenerative disorder

185

949

1.34

3.41

1.1

34.56

34.84

mmol/l

0.06

146

790

Redundant prepuce, phimosis and paraphimosis

406

1.61

3.41

1.5

1.2

30.47

35.74

mmol/l

1.26

358

Irregular menses

136

771

1.39

3.38

1.8

1.3

31.99

33.35

mmol/l

0.29

119

665

Other arthrosis

195

1023

1.32

3.38

1.2

1.1

33.92

34.91

mmol/l

0.23

163

880

Conjunctivitis

265

1751

1.27

3.38

1.3

32.57

34.00

mmol/l

0.52

228

1521

Injuries to the neck

474

1.56

3.38

1.3

1.2

31.20

35.61

mmol/l

0.91

411

Other disorders of the musculoskeletal system and connective tissue

366

1.65

3.35

1.3

1.1

32.37

35.06

mmol/l

0.45

309

Gout, unspecified

523

1.53

3.34

1.2

1.1

33.42

35.54

mmol/l

0.40

442

AV-block

367

1.60

3.33

1.1

1.2

36.91

35.94

mmol/l

0.12

304

Zoster [herpes zoster]

191

1436

1.31

3.29

1.2

34.14

34.36

mmol/l

0.04

160

1207

102

661

1.46

3.28

1.1

31.15

35.58

mmol/l

1.51

537

Zoster [herpes zoster]

494

1.54

3.27

1.3

1.1

34.54

34.21

mmol/l

0.04

407

Coxarthrosis [arthrosis of hip](FG)

204

1101

1.31

3.26

1.1

33.08

34.82

mmol/l

0.54

168

939

Periapical abscess

150

1108

1.36

3.26

1.2

29.24

34.77

mmol/l

2.78

134

962

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

192

990

1.32

3.26

1.1

35.62

33.49

mmol/l

0.57

160

816

Flat foot [pes planus] (acquired)

198

1.88

3.24

1.1

1.2

30.95

34.59

mmol/l

0.49

172

Malignant neoplasm of respiratory system and intrathoracic organs

436

1.53

3.24

1.2

1.1

35.87

34.86

mmol/l

0.15

357

Covid-19 suspected case

418

1.58

3.18

1.5

1.3

35.62

34.22

mmol/l

0.16

367

Rheumatism, unspecified

303

1.69

3.16

1.3

1.2

30.07

34.28

mmol/l

0.82

256

Progressive vascular leukoencephalopathy

104

2.23

3.16

1.3

1.1

27.53

36.05

mmol/l

1.18

Malignant neoplasm of bronchus and lung, including Hilmo

462

1.51

3.14

1.2

1.1

35.18

34.45

mmol/l

0.11

377

Undefined dementia

307

1.66

3.14

1.1

30.83

34.72

mmol/l

0.72

239

Congenital absence, atresia and stenosis of large intestine

8.25

3.14

4.8

4.1

28.02

35.13

mmol/l

—

Other disorders of veins

148

1092

1.35

3.13

1.1

1.2

33.10

34.06

mmol/l

0.22

123

923

Cardiodefibrillation

141

1037

1.36

3.12

1.1

37.33

34.75

mmol/l

0.61

120

866

Inflammatory bowel disease, strict (require KELA)

468

1.54

3.11

1.8

1.2

37.19

35.36

mmol/l

0.19

411

Pacemaker

139

980

1.36

3.10

1.2

35.87

35.33

mmol/l

0.10

122

811

Caries of enamel

297

1734

1.24

3.08

1.5

1.4

31.92

34.03

mmol/l

0.82

268

1504

Colonic or urogenital fistula

631

1.46

3.08

1.5

1.2

35.40

35.08

mmol/l

0.04

548

Glaucoma suspect

144

1068

1.35

3.08

1.1

1.2

30.45

34.75

mmol/l

1.87

127

896

Other deformities of toe(s)

2.52

3.04

1.1

31.20

32.12

mmol/l

—

Osteosarcoma

10.52

3.01

3.4

1.8

45.20

32.00

mmol/l

—

Use of pramipexole

602

1.47

3.00

1.1

32.92

34.52

mmol/l

0.31

507

Melanocytic naevi

676

1.44

3.00

1.1

1.2

28.90

35.10

mmol/l

1.84

581

Thyrotoxicosis

635

1.45

2.99

1.2

31.47

33.90

mmol/l

0.51

528

Dermatophytosis

202

1577

1.28

2.97

1.2

33.72

35.06

mmol/l

0.39

172

1352

Open wound of forearm

197

1.83

2.97

1.4

1.2

35.72

36.06

mmol/l

0.03

175

Atrophic disorders of skin

340

1.62

2.96

1.2

1.1

35.23

34.71

mmol/l

0.05

288

Subjective visual disturbances

621

1.45

2.94

1.3

1.2

32.39

35.67

mmol/l

0.60

539

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

468

1.52

2.91

1.0

1.1

34.74

34.24

mmol/l

0.08

392

Other extrapyramidal and movement disorders in other diseases

631

1.45

2.91

1.2

32.32

34.69

mmol/l

0.49

537

Acute peritonitis

142

1.98

2.90

2.0

1.2

35.73

33.92

mmol/l

0.12

129

ILD, hospital admissions

397

1.57

2.89

1.3

1.1

32.56

34.34

mmol/l

0.29

336

Melanocytic naevi of trunk

243

1.73

2.89

1.1

1.2

29.25

34.59

mmol/l

0.71

214

Necrotizing fasciitis

6.85

2.89

1.0

39.67

26.00

mmol/l

—

Basal cell carcinoma

174

921

1.31

2.88

1.1

1.2

36.23

33.92

mmol/l

0.61

147

757

Arthropathies

312

1290

1.23

2.86

1.6

1.4

33.88

34.90

mmol/l

0.33

275

1132

Enthesopathies of lower limb, excluding foot

438

1.53

2.85

1.1

1.2

31.19

36.12

mmol/l

1.23

381

Seronegative rheumatoid arthritis

267

1.69

2.84

1.2

1.1

29.14

34.00

mmol/l

0.99

223

Polyarthrosis

534

1.46

2.84

1.2

1.1

33.84

34.06

mmol/l

0.03

453

HSIL lesion of the cervix uteri, vagina or vulva

267

1.69

2.84

1.6

1.3

34.91

33.89

mmol/l

0.09

231

Gout, idiopatic and unspecified

651

1.43

2.83

1.2

1.1

33.47

35.79

mmol/l

0.49

544

Pain and other conditions associated with female genital organs and menstrual cycle

308

1.61

2.83

1.4

1.3

30.64

34.22

mmol/l

0.55

267

Arthrosis

249

1091

1.25

2.83

1.1

1.2

34.46

34.86

mmol/l

0.10

212

941

Palmar fascial fibromatosis [Dupuytren]

368

1.58

2.82

1.2

1.1

39.35

35.81

mmol/l

0.56

309

Salpingitis and oophoritis

392

1.56

2.81

1.4

1.2

32.67

33.32

mmol/l

0.08

326

Interstitial lung disease endpoints

408

1.55

2.81

1.3

1.2

32.48

34.20

mmol/l

0.29

342

Interstitial lung disease

408

1.55

2.81

1.3

1.2

32.48

34.20

mmol/l

0.29

342

Allergic conjunctivitis

187

1421

1.28

2.81

1.3

33.57

33.73

mmol/l

0.03

161

1228

Diseases of inner ear

201

1530

1.27

2.81

1.1

1.2

32.75

34.25

mmol/l

0.46

166

1293

Localized swelling, mass and lump of skin and subcutaneous tissue

114

829

1.38

2.79

1.4

1.2

32.24

34.65

mmol/l

0.68

100

713

Burns and corrosions

299

1.64

2.79

1.6

1.3

32.80

36.36

mmol/l

0.44

271

Car occupant injured in other and unspecified transport accidents

369

1.58

2.79

1.5

1.2

36.23

35.69

mmol/l

0.05

323

Congenital malformations of heart and great arteries

320

1.61

2.77

1.6

1.9

36.03

35.74

mmol/l

0.03

297

Infective dermatitis

254

1.70

2.77

1.0

1.2

30.24

35.91

mmol/l

1.23

220

Keratitis

121

890

1.36

2.77

1.3

1.2

31.09

34.75

mmol/l

1.22

106

760

Rheumatoid arthritis, including avohilmo

142

1071

1.33

2.75

1.2

32.43

34.46

mmol/l

0.55

113

905

Malignant neoplasm of kidney, except renal pelvis

210

1.77

2.74

1.1

1.2

35.71

34.37

mmol/l

0.11

179

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

196

1.79

2.71

1.1

28.57

35.29

mmol/l

1.52

170

Congenital malformations of gallbladder, bile ducts and liver

3.52

2.71

1.7

1.9

24.73

31.00

mmol/l

—

Use of biperiden

2.15

2.71

1.2

1.1

24.14

35.41

mmol/l

2.30

Other interstitial pulmonary diseases

412

1.53

2.70

1.3

1.1

32.48

34.56

mmol/l

0.36

346

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.79

2.68

6.7

2.0

46.11

33.33

mmol/l

—

Burns and corrosions of external body surface, specified by site

234

1.72

2.68

1.6

1.3

33.21

37.74

mmol/l

0.51

219

Myocardial infarction, unclassifiable

572

1.42

2.66

1.2

1.1

33.63

35.30

mmol/l

0.34

463

Disorders of vestibular function (Vertigo)

177

1360

1.28

2.66

1.1

1.2

32.45

34.53

mmol/l

0.63

143

1150

Disorders of muscles

205

1.76

2.64

1.1

1.2

26.18

34.88

mmol/l

2.09

174

Basal cell carcinoma, including avohilmo

178

954

1.29

2.63

1.1

1.2

35.81

33.64

mmol/l

0.59

153

783

Other hearing loss

112

803

1.37

2.63

1.6

1.2

34.05

34.84

mmol/l

0.16

665

ILD, hospital admissions 1, main diag only

353

1.56

2.58

1.3

1.1

32.95

34.42

mmol/l

0.22

303

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

177

1351

1.27

2.56

1.3

34.27

33.71

mmol/l

0.13

154

1165

Other noninflammatory disorders of vulva and perineum

178

1.80

2.55

1.6

1.1

24.47

33.03

mmol/l

2.27

151

Hyperparathyroidism

527

1.45

2.53

1.2

1.1

30.57

34.00

mmol/l

0.73

426

Cervicobrachial syndrome

452

1.49

2.51

1.4

1.1

32.49

36.02

mmol/l

0.73

392

Sequelae of other external causes

115

2.01

2.51

1.2

1.1

26.65

33.25

mmol/l

1.15

106

Other hammer toe(s) (acquired)

469

1.46

2.50

1.1

1.2

32.69

34.18

mmol/l

0.25

399

Vascular dementia (subcortical)

2.12

2.49

1.1

37.16

33.73

mmol/l

0.35

Other neurotic disorders

2.12

2.49

1.5

1.1

24.13

34.90

mmol/l

1.71

Allergic rhinitis

644

1.40

2.48

1.6

1.7

30.11

35.83

mmol/l

1.54

577

Ulcerative proctitis

2.11

2.48

1.3

1.2

28.38

35.44

mmol/l

1.31

Abnormal findings on diagnostic imaging of other body structures

317

1.58

2.48

1.3

1.2

34.87

34.75

mmol/l

0.01

271

Polycythaemia vera

2.21

2.48

1.1

1.2

33.52

33.28

mmol/l

0.02

Psoriasis vulgaris

432

1.49

2.40

1.3

1.2

34.41

35.28

mmol/l

0.11

377

Anterior Iridocyclitis

473

1.46

2.40

1.1

1.2

36.13

35.42

mmol/l

0.09

407

Failure and rejection of transplanted organs and tissues

3.38

2.40

2.0

1.6

21.22

31.16

mmol/l

—

Valvular operations

312

1.57

2.40

1.4

1.2

36.08

35.55

mmol/l

0.05

264

In situ neoplasms

139

1070

1.30

2.38

1.1

1.2

33.56

34.63

mmol/l

0.25

118

885

Pollen allergy

356

1.53

2.37

1.6

2.0

31.42

35.77

mmol/l

0.64

333

Routine general health check-up of defined subpopulation

3.66

2.36

1.1

1.3

41.50

40.49

mmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

175

947

1.27

2.35

1.1

1.2

36.95

33.77

mmol/l

0.93

147

778

Embolic stroke

111

1.99

2.35

1.2

32.33

35.43

mmol/l

0.29

Thiazolidinediones

275

1.61

2.34

1.2

1.1

30.22

34.83

mmol/l

0.87

241

Superficial injury of lower leg

576

1.41

2.33

1.4

1.2

34.39

35.13

mmol/l

0.10

494

Other bursopathies

299

1.58

2.32

1.1

35.61

34.01

mmol/l

0.18

247

Cholelithiasis, broad definition with cholecystitis

300

1689

1.20

2.32

1.4

1.1

34.40

34.65

mmol/l

0.07

247

1444

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

199

1.72

2.31

1.3

1.1

22.45

34.13

mmol/l

3.77

172

Alzheimer’s disease (Late onset)

101

626

1.36

2.30

1.1

34.22

34.86

mmol/l

0.10

520

Malignant neoplasm of skin

185

1011

1.26

2.29

1.1

36.71

33.57

mmol/l

0.96

154

830

Coxarthrosis

183

962

1.26

2.28

1.1

33.91

34.52

mmol/l

0.14

151

824

Superficial injury of thorax

332

1.54

2.28

1.2

33.00

36.07

mmol/l

0.41

286

Bronchiectasis

185

1.74

2.28

1.3

1.2

31.08

34.29

mmol/l

0.32

165

Iridocyclitis

554

1.41

2.27

1.2

36.55

34.52

mmol/l

0.33

474

Other ulcerative colitis

2.03

2.26

2.1

1.2

26.58

34.04

mmol/l

1.10

Acute and subacute iridocyclitis

447

1.46

2.25

1.2

36.65

35.03

mmol/l

0.22

381

Benign neoplasm: Sigmoid colon

489

1.44

2.23

1.3

1.1

33.33

35.05

mmol/l

0.22

417

Spondylolisthesis/Spondylolysis

415

1.47

2.23

1.0

1.2

30.96

36.46

mmol/l

1.17

360

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.13

2.23

6.7

1.8

46.11

37.11

mmol/l

—

Complications of labour and delivery

122

887

0.76

2.22

1.2

31.79

32.67

mmol/l

0.18

107

758

Malignant neoplasm of digestive organs

144

885

1.29

2.22

1.3

1.2

35.24

34.15

mmol/l

0.22

130

730

Disorders of synovium and tendon

177

1240

1.25

2.22

1.2

35.49

34.27

mmol/l

0.26

151

1073

Other specified and unspecified retinal disorders

2.21

1.3

1.2

33.19

34.27

mmol/l

0.07

Injury of eye and orbit

256

1.61

2.20

2.0

1.2

37.29

36.55

mmol/l

0.08

225

Sequelae of injuries of upper limb

195

1.70

2.18

1.1

1.2

39.72

35.88

mmol/l

0.27

175

Presbycusis

405

1.47

2.18

1.2

1.1

34.18

34.13

mmol/l

0.01

322

Special screening examination for infectious and parasitic diseases

233

1.55

2.18

1.3

1.1

39.19

35.69

mmol/l

0.35

210

Other joint disorders

289

1275

1.20

2.17

1.6

1.4

33.56

34.88

mmol/l

0.47

249

1117

Necrosis of pulp, including avohilmo

171

1365

1.25

2.17

1.6

1.2

33.11

34.86

mmol/l

0.45

145

1194

Seropositive rheumatoid arthritis, wide

729

1.35

2.17

1.2

32.52

34.49

mmol/l

0.41

615

Herpesviral [herpes simplex] infections

534

1.41

2.16

1.2

32.00

34.42

mmol/l

0.31

456

Nonsuppurative otitis media

396

1.44

2.15

2.5

1.8

28.35

36.51

mmol/l

2.50

359

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

242

1.62

2.15

1.1

34.57

34.79

mmol/l

0.02

204

Gout, strict definition

460

1.44

2.15

1.1

32.96

35.29

mmol/l

0.40

391

Atopic dermatitis, strict definition with reimbursement

581

1.38

2.15

1.6

1.7

33.76

35.30

mmol/l

0.24

523

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

337

1.51

2.13

1.1

37.83

33.44

mmol/l

0.59

273

Memory loss

228

1.63

2.11

1.1

31.37

34.84

mmol/l

0.48

189

All dysplastic lesions of the cervix uteri, vagina or vulva

439

1.44

2.09

1.4

1.3

32.29

33.70

mmol/l

0.17

379

Malignant neoplasm of bone and articular cartilage of limbs

5.12

2.08

3.4

1.4

45.20

33.00

mmol/l

—

malignant neoplasm of female genital organs

452

1.43

2.08

1.2

1.1

33.82

33.63

mmol/l

0.02

363

Varicose veins

223

1389

1.21

2.08

1.2

1.1

34.02

34.09

mmol/l

0.02

195

1159

Acute lymphocytic leukaemia, helper endpoint

3.57

2.07

2.4

3.9

24.43

29.20

mmol/l

—

Acute lymphocytic leukaemia, including Hilmo

3.57

2.07

2.4

3.9

24.43

29.20

mmol/l

—

Acute lymphocytic leukaemia

3.57

2.07

2.4

3.9

24.43

29.20

mmol/l

—

Malignant neoplasm of bronchus and lung

384

1.43

2.04

1.2

1.1

36.22

35.19

mmol/l

0.14

319

Herpesviral [herpes simplex] infections

246

1.59

2.03

1.2

29.66

34.76

mmol/l

0.72

211

Dementia in Alzheimer disease

441

1.40

2.03

1.1

30.86

34.85

mmol/l

1.03

361

Acetic acid derivatives and related substances

104

404

1.34

2.02

1.3

1.2

34.10

33.69

mmol/l

0.06

356

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

177

1.70

2.02

1.7

1.2

37.24

34.58

mmol/l

0.27

158

Brain glioblastoma and astrocytoma

3.10

2.02

1.1

34.31

33.96

mmol/l

—

Exposure to other and unspecified inanimate mechanical forces

140

1.79

2.00

1.8

1.3

33.13

34.10

mmol/l

0.08

130

Seborrhoeic dermatitis

216

1.63

2.00

1.1

1.3

29.37

36.30

mmol/l

0.82

191

Atopic dermatitis

167

1103

1.24

1.98

1.5

32.35

35.30

mmol/l

0.91

134

977

Retinal vascular occlusion

328

1.50

1.98

1.4

1.2

33.63

33.77

mmol/l

0.02

265

Other and unspecified vascular occlusions

248

1.58

1.97

1.4

1.1

34.59

34.83

mmol/l

0.02

200

Flatulence and related conditions

3.37

1.97

2.0

1.4

17.27

35.10

mmol/l

—

D07AA Corticosteroids, weak (group I)

344

1.48

1.97

1.2

1.7

29.91

34.71

mmol/l

0.85

314

Fenamates

270

1.46

1.96

1.2

1.1

37.63

33.45

mmol/l

0.74

240

Voice disturbances

674

1.34

1.94

1.1

1.2

34.26

34.17

mmol/l

0.01

577

Thyrotoxicosis with diffuse goitre

281

1.53

1.94

1.1

1.2

36.95

33.34

mmol/l

0.41

241

Other and unspecified nerve root and plexus disorders, also in other diseases

420

1.43

1.94

1.2

31.43

35.46

mmol/l

0.74

370

Disorders in reading

2.75

1.93

2.0

2.5

40.11

41.22

mmol/l

—

Alzheimer disease

134

772

1.27

1.93

1.1

35.02

mmol/l

0.00

103

642

Methotrexate

314

1.50

1.92

1.6

1.2

34.09

34.49

mmol/l

0.04

270

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

2.26

1.91

1.3

1.2

23.13

34.01

mmol/l

—

Retinal vascular disorders

331

1.48

1.90

1.4

1.2

33.63

33.87

mmol/l

0.03

268

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

600

1.35

1.89

1.1

1.2

35.38

34.99

mmol/l

0.05

532

Polymyalgia rheumatica

373

1.45

1.88

1.2

1.1

32.69

34.04

mmol/l

0.20

303

Radiculopathy

365

1.46

1.87

1.2

1.1

33.18

36.27

mmol/l

0.56

303

Other peripheral vertigo

228

1.58

1.87

1.2

1.1

32.71

35.35

mmol/l

0.32

197

Vasomotor rhinitis (mode)

151

1.73

1.87

1.5

1.1

33.67

35.19

mmol/l

0.14

134

Other maternal disorders predominantly related to pregnancy

100

817

0.77

1.86

1.2

1.3

32.89

32.49

mmol/l

0.06

699

Dislocation, sprain and strain of joints and ligaments at neck level

252

1.55

1.86

1.3

1.2

35.08

36.03

mmol/l

0.08

228

Bullous disorders

144

1.74

1.85

1.1

1.2

41.41

34.83

mmol/l

0.62

130

Other congenital malformations of upper alimentary tract

3.59

1.85

2.0

2.2

29.17

34.37

mmol/l

—

Cholecystitis

350

1.46

1.84

2.3

1.1

33.01

34.62

mmol/l

0.17

301

Ulcerative colitis, NAS

285

1.51

1.83

1.7

1.2

32.12

34.64

mmol/l

0.26

250

Other benign neoplasms of skin

131

1041

1.26

1.83

1.1

1.2

32.37

35.20

mmol/l

0.72

111

879

Delivery

681

0.77

1.82

1.1

1.2

33.63

34.04

mmol/l

0.06

576

Strabismus

646

1.33

1.81

1.5

1.4

33.55

34.84

mmol/l

0.19

571

Other/unspecified seropositive rheumatoid arthritis

726

1.31

1.81

1.2

32.79

34.53

mmol/l

0.34

612

Inguinal hernia

193

1066

1.21

1.79

1.2

35.60

35.04

mmol/l

0.13

165

920

Other and unspecified epidermal thickening

2.18

1.78

1.7

1.3

51.01

32.43

mmol/l

0.99

Coxibs

102

410

1.31

1.77

1.2

39.64

34.15

mmol/l

1.30

362

Striking against or struck by other objects

754

1.30

1.77

1.6

1.4

32.75

35.85

mmol/l

0.69

672

Open wound of wrist and hand

128

996

1.26

1.77

1.3

35.48

34.66

mmol/l

0.15

108

876

Other disorders of cornea

216

1.58

1.76

1.4

1.2

34.12

34.66

mmol/l

0.05

184

Temporomandibular joint disorders, including avohilmo

118

918

1.27

1.76

1.3

1.4

32.74

34.59

mmol/l

0.35

100

788

Olecranon bursitis

124

1.78

1.76

1.1

30.11

33.88

mmol/l

0.42

105

Anomalies of dental arch relationship, including avohilmo

371

1.41

1.74

2.3

1.8

30.90

35.79

mmol/l

1.11

338

Alzheimer’s disease, strict definition

104

665

1.29

1.73

1.1

34.92

34.71

mmol/l

0.03

553

Use of other anti-dementia drugs

114

742

1.28

1.73

1.1

33.48

35.19

mmol/l

0.38

616

Use of memantine

114

742

1.28

1.73

1.1

33.48

35.19

mmol/l

0.38

616

Single spontaneous delivery

678

0.77

1.73

1.1

1.2

34.00

33.86

mmol/l

0.02

574

Inguinal hernia, bilateral

225

1.56

1.73

1.2

35.19

36.24

mmol/l

0.07

197

Retinal detachments and breaks

125

997

1.26

1.72

1.2

32.35

35.03

mmol/l

0.79

110

831

Disturbance of activity and attention

182

1.62

1.72

1.8

2.8

35.27

35.87

mmol/l

0.05

176

Nail disorders

164

1.65

1.67

1.2

1.3

27.95

35.12

mmol/l

1.07

148

Suppurative and unspecified otitis media

651

1.29

1.66

1.5

1.6

30.48

35.88

mmol/l

1.66

579

Familial hypercholesterolemia, with ischemic heart disease

236

1.53

1.65

1.1

33.07

35.25

mmol/l

0.23

195

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

120

1.76

1.62

1.0

1.2

28.33

34.54

mmol/l

0.72

104

Rosacea

237

1.52

1.62

1.1

33.86

35.04

mmol/l

0.09

208

Communicating hydrocephalus

2.16

1.61

1.3

35.50

32.86

mmol/l

0.24

Alzheimer disease, including avohilmo

151

869

1.23

1.61

1.1

36.48

35.04

mmol/l

0.30

115

722

Injury of unspecified body region

174

1.61

1.60

1.6

1.4

33.06

34.47

mmol/l

0.08

156

Pregnancy with abortive outcome

156

989

0.82

1.59

1.2

32.81

32.97

mmol/l

0.03

129

843

Inguinal or femoral hernia, bilateral

230

1.53

1.59

1.2

35.19

36.35

mmol/l

0.08

202

Pleural plaque with presence of asbestos

175

1.61

1.57

1.1

37.40

33.67

mmol/l

0.40

153

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

716

1.29

1.57

1.2

32.61

34.30

mmol/l

0.31

605

Injuries to the wrist and hand

335

2035

1.14

1.55

1.2

1.3

36.02

33.93

mmol/l

0.83

280

1763

Bilateral cryptorchidism (undescended testicles)

3.48

1.54

4.4

2.3

54.60

32.67

mmol/l

—

Seborrhoeic keratosis

622

1.30

1.54

1.2

1.1

36.47

34.86

mmol/l

0.26

524

Other disorders of the genitourinary system

348

1.41

1.53

1.6

1.1

35.15

33.68

mmol/l

0.17

291

Adverse effects, not elsewhere classified

434

1.36

1.50

2.4

1.4

35.67

34.43

mmol/l

0.13

384

Other inflammation of eyelid

316

1.43

1.50

1.1

1.2

28.04

34.54

mmol/l

2.07

273

Noninflammatory disorders of female genital tract

132

536

1.24

1.49

2.1

1.2

35.13

33.82

mmol/l

0.26

114

460

Inflammatory diseases of female pelvic organs

187

1159

1.19

1.48

1.4

1.2

32.23

32.82

mmol/l

0.14

164

980

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

351

1.40

1.46

1.2

32.57

35.02

mmol/l

0.38

300

Benign neoplasm of breast

293

1.44

1.45

1.2

1.1

34.94

33.56

mmol/l

0.12

247

Malignant neoplasm, without specification of site

1.93

1.44

1.0

1.2

29.64

35.18

mmol/l

0.50

Presence of other devices

672

1.28

1.41

1.3

1.2

31.42

35.85

mmol/l

1.21

563

Delivery, wide proxy

582

0.78

1.40

1.1

1.2

36.00

33.62

mmol/l

0.39

492

Squamous cell neoplasms and carcinomas of the skin

213

1.51

1.40

1.1

1.2

38.65

33.12

mmol/l

0.58

169

Dentofacial anomalies [including malocclusion]

206

1416

1.17

1.39

1.5

1.3

32.56

34.15

mmol/l

0.43

179

1229

Coxarthrosis, primary, with hip surgery

177

1403

1.18

1.39

1.1

32.71

34.67

mmol/l

0.59

147

1182

Ovarian cyst

108

499

1.25

1.38

1.4

1.1

35.40

32.90

mmol/l

0.48

427

Other/unspecified synovitis and tenosynovitis

230

1.48

1.38

1.2

30.96

33.44

mmol/l

0.27

191

Excessive, frequent and irregular menstruation

119

528

1.24

1.38

2.4

1.2

31.15

33.43

mmol/l

0.54

102

453

Spirochaetal infections, other/unspecified

190

1.53

1.37

1.1

1.2

45.55

33.90

mmol/l

1.00

168

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

2.96

1.36

1.4

1.2

60.20

26.06

mmol/l

—

Parkinson's disease, including avohilmo

425

1.34

1.36

1.1

32.35

35.17

mmol/l

0.62

357

Outcome of delivery

139

0.53

1.35

1.4

1.3

37.00

32.74

mmol/l

0.23

125

Conjunctivitis (acute, non atopic)

668

1.27

1.35

1.2

1.4

29.38

34.71

mmol/l

1.72

583

Gonarthrosis

214

1046

1.17

1.35

1.1

34.61

34.85

mmol/l

0.05

175

899

Cholelithiasis

276

1667

1.14

1.34

1.3

1.2

34.83

34.74

mmol/l

0.02

226

1426

Spontaneous abortion

709

0.79

1.34

1.1

1.2

31.00

32.80

mmol/l

0.38

608

Other skin changes

470

1.32

1.33

1.4

1.2

32.36

34.89

mmol/l

0.36

397

Primary coxarthrosis, bilateral

108

879

1.23

1.32

1.1

33.12

34.46

mmol/l

0.27

734

Malignant neoplasm, without specification of site, including Hilmo

113

1.69

1.31

1.0

1.2

29.47

35.51

mmol/l

0.68

Fracture at wrist and hand level

101

815

1.24

1.31

1.4

1.3

34.60

34.20

mmol/l

0.06

717

Otitis externa

525

1.30

1.29

1.2

1.3

32.82

35.03

mmol/l

0.35

457

Coxarthrosis, primary

218

1600

1.15

1.28

1.1

32.94

34.51

mmol/l

0.51

180

1349

Ganglion

447

1.32

1.28

1.3

1.2

37.00

34.99

mmol/l

0.21

378

Pre-eclampsia or eclampsia

387

1.35

1.27

1.2

27.62

34.06

mmol/l

1.79

334

Disorders of puberty, all

2.30

1.27

8.5

2.3

22.79

35.17

mmol/l

—

Myocardial infarction, with ST-elevation

439

1.32

1.27

1.1

36.77

35.53

mmol/l

0.15

370

Other fall from one level to another

535

1.29

1.27

1.5

1.4

38.01

35.63

mmol/l

0.28

481

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

285

1.41

1.27

1.3

32.59

33.97

mmol/l

0.16

246

Atopic dermatitis, strict definition

585

1.27

1.26

1.6

1.9

34.98

35.16

mmol/l

0.02

528

Synovial cyst of popliteal space [Baker]

154

1.56

1.25

1.1

37.87

33.70

mmol/l

0.44

125

Brain glioblastoma

2.42

1.24

1.0

1.1

32.42

33.76

mmol/l

—

Pleural plaque

236

1.44

1.24

1.1

37.82

35.60

mmol/l

0.24

204

Benign paroxysmal vertigo

102

832

1.23

1.24

1.1

34.63

34.55

mmol/l

0.01

695

Biological medication for rheuma

329

1.37

1.23

2.0

1.3

37.78

35.44

mmol/l

0.15

295

Non-Hodgkin lymphoma, all

100

1.71

1.23

1.3

1.2

29.12

35.21

mmol/l

0.88

Other peripheral vascular diseases

171

1.52

1.23

1.2

32.49

35.09

mmol/l

0.28

149

Abnormal serum enzyme levels

741

1.24

1.23

1.2

35.57

35.76

mmol/l

0.02

639

Benign lipomatous neoplasm

765

0.77

1.21

1.2

35.45

34.63

mmol/l

0.10

655

Benign neoplasm: Small intestine

1.73

1.21

1.4

1.1

28.09

34.34

mmol/l

0.86

Sulfasalazine

619

1.26

1.21

1.3

1.2

31.78

35.40

mmol/l

0.73

535

Hypertrichosis

2.32

1.19

1.0

1.6

27.50

37.27

mmol/l

—

Mental and behavioural disorders due to cannabinoids

2.31

1.18

1.3

28.67

38.96

mmol/l

—

Other disorders of conjunctiva

349

1.35

1.18

1.1

32.96

33.98

mmol/l

0.11

298

Entropion and trichiasis of eyelid

214

1.45

1.18

1.0

1.1

39.52

35.02

mmol/l

0.39

184

Oxicams

380

1.26

1.17

1.1

36.29

33.93

mmol/l

0.40

333

Aortic aneurysm

540

1.27

1.17

1.2

1.1

35.34

36.46

mmol/l

0.15

454

Follicular cysts of skin and subcutaneous tissue

428

1.31

1.17

1.2

27.82

36.44

mmol/l

3.21

373

Nonspecific lymphadenitis

102

1.67

1.16

1.1

1.2

28.65

35.55

mmol/l

0.65

Other female pelvic inflammatory diseases

369

1.33

1.14

1.3

1.2

30.77

33.14

mmol/l

0.34

306

Other strabismus

508

1.28

1.12

1.5

34.66

35.03

mmol/l

0.04

448

Pregnancy, childbirth and the puerperium

541

0.81

1.09

1.1

1.3

35.72

33.93

mmol/l

0.26

453

Brain meningioma

112

1.61

1.09

1.2

38.89

35.51

mmol/l

0.21

100

Parkinson's disease

407

1.30

1.08

1.1

31.63

34.84

mmol/l

0.69

344

Other disorders of bone

390

1.31

1.08

1.1

1.2

28.26

35.68

mmol/l

1.87

339

Sulfonylureas

126

847

1.19

1.07

1.2

1.1

29.09

34.63

mmol/l

2.84

101

706

Mixed specific developmental disorders

1.73

1.07

1.9

2.8

36.00

32.93

mmol/l

0.20

Use of donepezil

653

0.78

1.06

1.1

32.49

34.26

mmol/l

0.26

533

Glaucoma-related operations

153

1.51

1.06

1.1

1.2

27.67

34.55

mmol/l

1.32

132

Hyperkinetic disorders

207

1.42

1.04

1.8

2.7

35.27

37.12

mmol/l

0.16

197

Adalimumab

162

1.48

1.04

2.5

1.3

43.89

37.38

mmol/l

0.28

149

Shoulder lesions

248

1337

1.12

1.01

1.2

34.26

34.21

mmol/l

0.01

213

1147

Effects of foreign body entering through natural orifice

555

1.24

1.00

1.2

1.3

29.61

36.39

mmol/l

2.21

494

Carpal tunnel syndrome

193

1496

1.14

1.00

1.2

32.33

34.52

mmol/l

0.72

161

1276

Carbimazole or st.post thyroidectomy, condition for graves disease

466

1.27

1.00

1.1

1.2

36.51

33.56

mmol/l

0.42

396

Dermatophytosis

308

1.33

0.99

1.1

1.2

32.66

35.59

mmol/l

0.39

269

Etanercept

115

1.57

0.99

1.8

1.4

29.05

36.49

mmol/l

0.75

108

Benign neoplasm: Parotid gland

164

1.47

0.99

1.1

44.65

34.53

mmol/l

0.70

144

Postmenopausal bleeding

102

453

1.20

0.98

1.1

33.41

32.65

mmol/l

0.11

381

Other disorders of penis

206

1.41

0.98

1.5

1.3

43.58

34.75

mmol/l

0.60

185

Wet age-related macular degeneration

549

1.24

0.97

1.1

34.40

34.65

mmol/l

0.03

449

Tuberculosis of other organs

1.81

0.97

1.3

1.2

30.22

34.74

mmol/l

—

Erosion and ectropion of cervix uteri

1.81

0.96

1.1

24.89

31.44

mmol/l

—

Gonarthrosis [arthrosis of knee](FG)

241

1249

1.12

0.96

1.1

35.03

34.88

mmol/l

0.03

197

1076

Benign neoplasm: Skin of other and unspecified parts of face

250

1.36

0.95

1.1

1.2

28.61

34.90

mmol/l

1.12

211

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

328

1.31

0.95

1.7

1.3

30.80

36.29

mmol/l

1.03

295

Other embolism and thrombosis

302

1.33

0.95

1.2

1.1

29.93

34.91

mmol/l

0.70

256

Brain meningioma, including Hilmo

117

1.54

0.93

1.2

38.89

35.20

mmol/l

0.24

103

Haemorrhoids and perianal venous thrombosis

759

1.20

0.93

1.1

31.65

35.47

mmol/l

1.04

644

Retinal detachment with retinal break

322

1.31

0.91

1.1

30.82

35.09

mmol/l

0.80

268

Lichen sclerosus et atrophicus

244

1.36

0.90

1.3

1.1

30.18

33.41

mmol/l

0.41

207

Diseases of external ear

106

901

1.18

0.90

1.3

1.2

32.53

34.76

mmol/l

0.50

769

Acute appendicitis, no complications

148

1285

1.15

0.90

1.4

1.2

37.35

34.21

mmol/l

0.79

127

1116

Other abnormal uterine and vaginal bleeding

447

1.22

0.90

1.3

1.1

32.28

33.19

mmol/l

0.13

378

Umbilical hernia

609

1.22

0.89

1.1

33.19

35.27

mmol/l

0.29

524

Superficial injury of shoulder and upper arm

236

1.36

0.89

1.2

26.02

36.25

mmol/l

1.99

211

Urticaria and erythema

104

884

1.18

0.89

1.5

1.4

33.25

34.94

mmol/l

0.38

765

Tuberculosis of other organs, strict

1.79

0.88

1.3

1.2

30.40

34.13

mmol/l

—

Scabies

1.65

0.88

1.2

1.3

24.00

37.14

mmol/l

1.68

Deviated nasal septum

756

1.19

0.87

1.2

1.1

35.21

35.84

mmol/l

0.12

661

Malignant neoplasm of breast, HER2-negative, including Hilmo

137

769

1.15

0.87

1.2

35.72

32.19

mmol/l

1.06

122

630

Malignant neoplasm of breast, including Hilmo

137

769

1.15

0.87

1.2

35.72

32.19

mmol/l

1.06

122

630

Birth asphyxia

1.96

0.85

1.8

2.5

32.37

35.16

mmol/l

—

Restless leg syndrome

317

1.30

0.85

1.0

1.2

29.67

34.76

mmol/l

1.07

272

Glaucoma, exfoliation

317

1.30

0.85

1.0

1.1

33.61

33.89

mmol/l

0.03

253

Parkinson's disease, strict definition

379

1.27

0.85

1.1

32.53

34.55

mmol/l

0.35

320

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.57

0.84

1.3

1.1

30.67

35.98

mmol/l

0.53

Ill-defined and unknown causes of mortality

213

1.36

0.84

1.2

1.1

36.35

34.47

mmol/l

0.14

180

Ulcerative colitis (strict definition, require KELA)

344

1.28

0.84

1.6

1.3

30.69

35.85

mmol/l

0.99

308

Infectious mononucleosis

114

0.53

0.82

1.0

1.4

19.33

36.69

mmol/l

—

109

Amputation of ankle bones

1.75

0.82

1.0

1.1

30.50

32.62

mmol/l

—

Non-small cell lung cancer, including Hilmo

350

1.27

0.82

1.1

37.37

35.12

mmol/l

0.31

289

Disorders of puberty

1.88

0.82

10.7

1.9

22.55

32.41

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

671

1.19

0.81

1.2

27.93

35.84

mmol/l

3.23

584

DVT of lower extremities

480

1.23

0.81

1.2

1.1

32.97

34.99

mmol/l

0.27

398

Diseases of middle ear and mastoid

155

1118

1.13

0.81

1.5

1.4

30.36

35.26

mmol/l

2.33

138

971

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

373

1.26

0.80

1.6

1.2

30.37

36.12

mmol/l

1.19

329

Adenomyosis (Endometriosis of uterus)

329

0.73

0.80

1.1

33.17

33.25

mmol/l

0.01

278

Circumscribed brain atrophy

1.73

0.80

1.1

1.2

29.80

33.92

mmol/l

—

Other noninflammatory disorders of uterus, except cervix

440

1.20

0.78

1.1

33.55

32.84

mmol/l

0.12

370

Other infections specific to the perinatal period

0.00

0.78

0.0

1.9

—

39.96

—

Cardiovascular disorders originating in the perinatal period

2.21

0.77

6.8

3.0

28.40

34.26

mmol/l

—

Bacterial sepsis of newborn

1.78

0.77

4.2

2.1

50.00

38.59

mmol/l

—

Appendectomy

182

1559

1.12

0.76

1.3

1.2

36.61

33.62

mmol/l

0.77

160

1346

Malignant neoplasm of small intestine

1.71

0.75

2.1

1.2

33.43

34.83

mmol/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

362

1.19

0.73

1.2

1.1

36.94

33.44

mmol/l

0.73

315

Tumor necrosis factor alpha inhibitors

298

1.28

0.73

2.2

1.3

40.66

34.79

mmol/l

0.40

269

Benign neoplasm of major salivary glands

219

1.33

0.73

1.1

44.15

34.75

mmol/l

0.83

186

Hirsutism in women

2.01

0.72

1.0

1.6

29.40

38.52

mmol/l

—

Other and unspecified rosacea

176

1.37

0.72

1.2

1.1

34.37

34.75

mmol/l

0.02

156

Benign neoplasm: Duodenum

1.67

0.72

1.5

1.1

30.09

34.62

mmol/l

—

Other abnormal products of conception

289

0.78

0.72

1.3

32.17

32.73

mmol/l

0.04

261

Rare circulating lymphoid malignancy, including Hilmo

1.58

0.71

1.8

2.2

31.83

36.42

mmol/l

0.37

Use of rivastigmine

469

1.21

0.71

1.1

36.80

34.48

mmol/l

0.29

370

Thoracic aortic aneurysm

317

1.26

0.71

1.3

1.1

34.99

35.64

mmol/l

0.06

277

Sarcoidosis

309

1.26

0.70

1.2

29.36

35.28

mmol/l

1.24

268

Malignant neoplasm of breast, HER2-negative

132

762

1.13

0.70

1.1

1.2

36.09

32.25

mmol/l

1.14

119

624

Premature rupture of membranes

214

0.73

0.70

1.1

1.5

37.41

35.07

mmol/l

0.15

190

Carcinoma in situ of skin of scalp and neck

1.65

0.68

1.1

40.79

34.45

mmol/l

—

Tinnitus

574

1.19

0.68

1.1

36.72

35.27

mmol/l

0.19

489

Malignant neoplasm of breast, ER-positive, including Hilmo

106

715

1.14

0.66

1.2

1.1

33.28

32.53

mmol/l

0.12

583

Male infertility

1.62

0.65

1.1

1.2

30.80

36.47

mmol/l

—

Unspecified lump in breast

385

1.22

0.65

1.1

1.2

29.82

34.25

mmol/l

0.81

324

Malignant neoplasm of breast

132

765

1.13

0.64

1.1

1.2

35.98

32.21

mmol/l

1.13

119

627

Use of levodopa decarboxylase inhibitor

359

1.23

0.63

1.2

1.1

35.80

35.18

mmol/l

0.09

302

Superficial injury of wrist and hand

423

1.21

0.63

1.4

1.3

38.51

34.05

mmol/l

0.54

378

ILD-related respiratory insufficiency

1.52

0.62

1.1

34.21

34.58

mmol/l

0.03

Other and unspecified tonsillitis

510

1.17

0.62

2.5

1.5

36.02

36.20

mmol/l

0.02

465

Rotator cuff syndrome

194

1268

1.10

0.61

1.2

1.1

32.92

34.11

mmol/l

0.32

168

1086

Scabies

262

1.26

0.60

1.2

1.5

31.25

35.39

mmol/l

0.47

241

Female genital prolapse

474

1.15

0.60

1.2

1.1

35.37

32.66

mmol/l

0.56

402

Complications associated with artificial fertilization

0.00

0.60

0.0

1.1

—

38.35

—

Muscle strain

1.57

0.60

1.3

1.1

20.64

35.51

mmol/l

—

Birth trauma

0.00

0.60

0.0

2.7

—

42.95

—

Mesial bite

0.00

0.60

0.0

2.0

—

36.57

—

Embedded teeth, including avohilmo

140

0.64

0.60

1.1

1.4

36.67

34.87

mmol/l

—

135

Malignant neoplasm of corpus uteri, including Hilmo

272

1.25

0.59

1.0

1.1

34.93

33.64

mmol/l

0.13

217

Adenocarcinoma and papillary adenocarcinoma of stomach

1.57

0.58

1.1

1.2

40.40

37.37

mmol/l

—

Malignant neoplasm of corpus uteri

237

1.27

0.58

1.0

1.1

36.24

33.98

mmol/l

0.22

187

Triptan medication for migraine, min. 3 purchases

132

904

1.11

0.58

1.3

33.69

33.78

mmol/l

0.02

117

785

Maternal care related to the fetus and amniotic cavity and possible delivery problems

477

0.86

0.57

1.2

1.4

36.27

32.79

mmol/l

0.57

415

Periodontal disease, other/unspecified

1.49

0.57

1.5

1.3

33.13

36.46

mmol/l

—

Pre-eclampsia

355

1.21

0.57

1.2

28.29

34.10

mmol/l

1.30

306

Normal-pressure hydrocephalus

132

1.37

0.57

1.2

33.78

35.49

mmol/l

0.13

114

Malignant neoplasm of breast, HER-positive

103

711

1.13

0.57

1.2

1.1

33.16

32.57

mmol/l

0.09

579

Sudden idiopathic hearing loss

229

1.27

0.56

1.0

1.2

31.83

34.13

mmol/l

0.27

196

Polyp of the female genital tract

485

1.14

0.56

1.1

35.61

32.89

mmol/l

0.49

414

Antepartum haemorrhage, not elsewhere classified

1.43

0.56

1.0

1.7

43.43

35.97

mmol/l

0.38

Plantar fascial fibromatosis

177

1.30

0.54

1.1

41.35

32.76

mmol/l

0.94

146

Benign neoplasm: salivary glands, exclude unknown (D119)

186

1.29

0.54

1.1

1.2

44.65

33.91

mmol/l

0.76

161

conjunctival haemorrhage

178

1.29

0.53

1.1

1.2

32.74

33.91

mmol/l

0.09

150

Injury of muscle and tendon at hip and thigh level

204

0.73

0.52

1.5

1.2

43.32

36.59

mmol/l

—

183

Postpartum care and examination

108

0.70

0.52

1.0

1.4

41.67

32.46

mmol/l

0.85

Fetus and newborn affected by maternal complications of pregnancy

1.51

0.52

2.8

26.50

34.53

mmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

150

1082

1.10

0.51

1.3

1.2

36.65

33.89

mmol/l

0.70

133

928

Anti-inflammatory and antirheumatic products, non-steroids

104

466

1.12

0.50

1.3

1.7

34.14

34.51

mmol/l

0.06

418

Anogenital herpesviral [herpes simplex] infection

144

1.32

0.50

1.4

1.2

37.26

35.74

mmol/l

0.11

136

Benign neoplasm: Caecum

279

1.22

0.50

1.1

37.68

34.45

mmol/l

0.36

240

Use of galantamine

226

1.24

0.48

1.2

34.87

34.57

mmol/l

0.02

180

Combinations of oral blood glucose lowering drugs

729

1.13

0.47

1.1

33.57

34.92

mmol/l

0.24

625

Malignant neoplasm of small intestine, including Hilmo

1.47

0.47

2.1

1.2

31.29

35.23

mmol/l

—

Pedal cyclist injured in transport accident

513

1.15

0.46

1.3

38.89

35.54

mmol/l

0.35

449

Artificial joint operation, meniscal resection

305

1864

1.06

0.46

1.2

1.1

34.73

34.09

mmol/l

0.18

252

1589

Phlebitis and thrombophlebitis (not including DVT)

551

1.14

0.46

1.2

40.24

34.97

mmol/l

0.71

456

Other and specified injuries of hip and thigh

1.43

0.46

1.3

1.1

36.43

34.76

mmol/l

—

Noise effects on inner ear

1.43

0.45

1.0

1.1

34.26

36.18

mmol/l

0.16

Primary open-angle glaucoma

111

973

1.10

0.45

1.1

31.92

34.77

mmol/l

0.72

796

Other blood glucose lowering drugs, excl. Insulins

431

1.16

0.45

1.2

1.1

29.25

34.53

mmol/l

1.15

365

Alzheimer’s disease (Atypical or mixed)

327

1.19

0.44

1.1

31.39

34.74

mmol/l

0.50

257

Impingement syndrome of shoulder

563

1.14

0.44

1.1

1.2

39.61

34.48

mmol/l

0.87

487

Cardiac murmurs and other cardiac sounds

191

1.24

0.43

1.7

1.8

31.42

34.37

mmol/l

0.44

171

Other disorders originating in the perinatal period

1.41

0.42

7.5

2.6

23.29

35.83

mmol/l

—

Toxic effect of ethanol

1.38

0.41

8.6

1.2

42.38

35.54

mmol/l

—

Cervical root disorders

0.00

0.41

0.0

1.0

—

33.69

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.41

0.0

1.1

—

31.69

—

Constitutional tall stature

0.00

0.41

0.0

2.4

—

34.59

—

Ovarian hyperstimulation (induction)

0.00

0.40

0.0

1.1

—

34.90

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.40

0.0

1.1

—

34.64

—

Benign neoplasm of ovary

464

1.14

0.40

1.3

1.2

37.50

33.66

mmol/l

0.57

384

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.40

0.0

1.0

—

35.13

—

Toxic effect of contact with venomous animals

1.37

0.40

1.1

1.4

35.25

33.63

mmol/l

0.12

Artrosis, including avohilmo

259

1336

1.06

0.39

1.1

1.2

34.76

mmol/l

0.00

221

1163

Postmenopausal atrophic vaginitis

443

1.11

0.39

1.1

35.22

32.52

mmol/l

0.46

378

Malignant neoplasm of gallbladder, including Hilmo

0.00

0.39

0.0

1.1

—

34.05

—

Spirochaetal infections, other/unspecified

770

0.90

0.38

1.1

1.2

40.96

35.22

mmol/l

0.89

663

Other disorders of amniotic fluid and membranes

155

0.76

0.38

1.2

1.5

31.17

34.83

mmol/l

0.20

135

Ulcerative colitis (strict definition, all Crohn cases excluded)

289

1.18

0.37

1.4

1.3

30.47

35.72

mmol/l

0.80

261

Polyarthritis, unspecified

1.33

0.37

1.8

1.3

28.82

32.66

mmol/l

—

Other disorders of male genital organs

1.33

0.37

1.0

1.3

41.64

33.94

mmol/l

—

Pregnancy hypertension

707

1.10

0.37

1.2

1.3

31.22

33.39

mmol/l

0.43

606

Disorders of eyelid in diseases classified elsewhere

1.31

0.37

1.0

1.2

27.94

32.32

mmol/l

—

Corneal ulcer

411

1.14

0.37

1.2

32.47

35.18

mmol/l

0.46

355

Macular pucker

430

1.14

0.37

1.2

1.1

34.03

34.93

mmol/l

0.08

359

Benign lipomatous neoplasm of other sites/unspecified

207

1.21

0.36

1.2

34.98

34.50

mmol/l

0.03

176

Meniscus derangement

166

1045

1.07

0.35

1.2

36.52

34.95

mmol/l

0.36

141

901

Lyme disease

765

0.90

0.35

1.1

1.2

40.96

35.28

mmol/l

0.88

659

Personal history of malignant neoplasm

144

1.25

0.35

1.8

1.3

32.86

34.34

mmol/l

0.09

128

Gonarthrosis,primary

299

1755

1.05

0.34

1.1

35.53

33.84

mmol/l

0.58

239

1504

Pediculosis, acariasis and other infestations

330

1.15

0.33

1.2

1.5

34.16

35.29

mmol/l

0.09

297

Use of ropinirole

0.67

0.33

1.0

1.2

20.67

34.77

mmol/l

—

Benign neoplasm of middle ear and respiratory system

164

1.22

0.32

1.5

1.2

28.90

34.73

mmol/l

0.58

144

Hydrocele

257

1.17

0.32

1.2

35.38

36.88

mmol/l

0.16

220

Other superficial mycoses

183

1.20

0.31

1.5

1.2

36.82

37.13

mmol/l

0.02

170

Dislocation, sprain and strain of joints and ligaments of knee

130

1282

0.93

0.31

1.4

1.2

33.54

34.88

mmol/l

0.33

118

1127

Hallux rigidus

342

1.14

0.31

1.1

1.2

31.33

34.63

mmol/l

0.41

293

Idiopathic gout

221

1.18

0.30

1.2

1.1

33.35

35.85

mmol/l

0.21

191

Female infertility

340

1.11

0.30

1.2

1.1

30.72

33.20

mmol/l

0.39

295

Appendicitis, broad definition

202

1736

1.05

0.29

1.3

1.2

36.16

34.11

mmol/l

0.60

178

1487

Benign neoplasm: Larynx

1.23

0.29

1.1

1.2

27.14

33.02

mmol/l

—

Serous carcinoma of ovary, including Hilmo

1.32

0.28

1.0

1.2

32.21

34.46

mmol/l

—

Medicines for HER+ breast cancer

115

1019

1.07

0.28

1.1

33.01

33.07

mmol/l

0.01

105

847

Injury of nerves at wrist and hand level

1.29

0.28

1.3

1.2

40.88

32.92

mmol/l

—

Glucosamine medication

170

1285

1.06

0.27

1.1

35.63

33.98

mmol/l

0.37

140

1069

Other spirochaetal diseases

772

0.92

0.27

1.2

41.90

35.36

mmol/l

1.09

664

Abnormal findings in secretions and smears from cervix uteri vagina vulva

109

770

1.07

0.26

1.3

1.2

33.88

33.04

mmol/l

0.14

655

Migraine, single triptan purchase ok & required. ICD-code if available is included

208

1343

1.05

0.26

1.4

35.72

33.96

mmol/l

0.53

180

1164

Triptan medication for migraine, single purchase ok

208

1343

1.05

0.26

1.4

35.72

33.96

mmol/l

0.53

180

1164

Menorrhagia

502

1.07

0.25

1.3

1.2

30.24

33.06

mmol/l

0.71

429

Spondyloarthritis

387

1.11

0.25

1.7

1.1

36.93

34.95

mmol/l

0.22

328

Other spirochaetal diseases

778

0.93

0.25

1.2

41.90

35.25

mmol/l

1.11

669

Benign neoplasm: Rectum

464

1.10

0.24

1.1

27.51

34.75

mmol/l

1.67

398

Propionic acid derivatives

465

1.07

0.24

1.3

1.7

33.90

34.50

mmol/l

0.10

417

Carcinoma in situ of other and unspecified sites

0.74

0.24

1.0

1.2

30.33

35.96

mmol/l

—

Diseases of appendix

203

1751

1.04

0.24

1.3

1.2

36.24

34.07

mmol/l

0.65

179

1501

Acute appendicitis

184

1643

1.05

0.23

1.4

1.2

36.66

34.20

mmol/l

0.69

160

1412

Urticaria

697

1.08

0.23

1.3

1.4

31.28

34.46

mmol/l

0.80

605

Internal derangement of knee

906

1.07

0.23

1.2

31.56

35.19

mmol/l

0.82

780

Gonarthrosis, primary, with knee surgery

195

1486

1.04

0.23

1.2

1.1

34.86

33.86

mmol/l

0.23

164

1258

Loose body in joint

1.28

0.23

1.2

1.1

28.60

32.18

mmol/l

—

Other congenital malformations of tongue, mouth and pharynx

1.28

0.23

2.4

2.2

48.00

35.21

mmol/l

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.22

0.0

2.5

—

27.90

—

Malignant neoplasm of gallbladder

0.00

0.21

0.0

1.1

—

37.00

—

Malignant neoplasm of penis, including Hilmo

0.00

0.21

0.0

1.1

—

27.91

—

Other benign neoplasm of uterus: Cervix uteri

0.00

0.21

0.0

1.1

—

31.20

—

Liposarcoma

0.00

0.21

0.0

1.1

—

32.27

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.1

—

28.33

—

Female infertility, cervical, vaginal, other or unspecified origin

329

1.09

0.21

1.2

1.1

32.06

33.45

mmol/l

0.17

287

Malignant neoplasm of other connective and soft tissue, including Hilmo

103

0.78

0.21

1.0

1.3

41.67

34.07

mmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

874

0.94

0.21

1.1

37.46

35.89

mmol/l

0.26

751

L02BG Aromatase inhibitors

904

1.06

0.21

1.1

32.97

33.02

mmol/l

0.01

747

Benign neoplasm: Rectum, anus and anal canal

537

1.08

0.20

1.2

1.1

27.18

34.81

mmol/l

2.07

458

Hordeolum and other deep inflammation of eyelid

112

0.80

0.20

1.2

1.3

38.44

36.36

mmol/l

—

105

Other congenital malformations of tongue, mouth and pharynx

1.19

0.19

2.2

42.00

34.10

mmol/l

—

Chronic suppurative otitis media, including avohilmo

193

1.14

0.19

1.1

1.4

31.73

36.15

mmol/l

0.48

174

Malignant melanoma, including Hilmo

423

1.09

0.19

1.1

30.98

34.57

mmol/l

0.61

348

Abrasion of teeth

811

1.06

0.19

1.2

30.67

35.41

mmol/l

1.15

693

Other, unspecified and serous retinal detachments

1.19

0.18

1.0

1.2

34.13

35.10

mmol/l

—

Other and unspecified disorders of vitreous body

117

1208

0.95

0.18

1.3

1.1

36.77

33.84

mmol/l

0.66

1022

Vestibular neuronitis

196

1.12

0.16

1.3

1.1

30.63

34.96

mmol/l

0.42

174

Benign neoplasm: Kidney

0.77

0.15

1.2

1.1

25.62

34.31

mmol/l

—

Disorders of breast

135

1180

1.04

0.15

1.2

32.75

32.99

mmol/l

0.04

107

1008

Ménière disease

236

1.10

0.14

1.0

1.1

27.88

35.10

mmol/l

1.05

201

Leiomyoma of uterus

176

1030

0.97

0.14

1.1

1.2

34.18

32.54

mmol/l

0.37

143

875

Disorders of vitreous body

153

1429

1.03

0.14

1.2

1.1

35.08

33.83

mmol/l

0.28

130

1208

Malignant neoplasm of breast, ER-negative, including Hilmo

605

1.06

0.14

1.2

1.1

37.95

33.04

mmol/l

1.14

489

Injury of muscle and tendon at wrist and hand level

295

1.09

0.14

1.1

1.2

33.52

35.61

mmol/l

0.19

261

Malignant melanoma

344

1.08

0.13

1.1

28.39

34.87

mmol/l

1.46

286

Benign neoplasm: Ascending colon

364

1.07

0.13

1.2

1.1

31.32

34.65

mmol/l

0.39

308

Benign neoplasm of urinary organs

107

0.84

0.13

1.6

1.1

33.30

34.94

mmol/l

—

N06DA Anticholinesterases

122

928

1.04

0.13

1.1

34.66

35.04

mmol/l

0.06

762

Use of anticholinesterases

122

928

1.04

0.13

1.1

34.66

35.04

mmol/l

0.06

762

Twin gestation

108

0.83

0.13

1.8

1.4

21.89

34.03

mmol/l

—

Multiple gestation

110

0.82

0.13

1.8

1.4

21.89

34.10

mmol/l

—

Malignant neoplasm of mesothelium and soft tissue

104

1.16

0.12

1.0

1.3

28.47

34.74

mmol/l

0.61

Malignant neoplasm of prostate, including Hilmo

408

1.05

0.12

1.1

1.2

35.56

34.21

mmol/l

0.22

348

Glucagon-like peptide-1 (GLP-1) analogues

629

1.05

0.12

1.2

33.20

35.43

mmol/l

0.42

545

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

629

1.05

0.12

1.2

33.20

35.43

mmol/l

0.42

545

Calculus of kidney and ureter

752

0.96

0.11

1.5

1.2

36.89

35.10

mmol/l

0.23

645

Disorders of vitreous body and globe

157

1467

1.03

0.11

1.2

1.1

35.12

33.85

mmol/l

0.29

133

1241

Contraceptive management

591

0.96

0.11

1.2

1.3

37.13

33.58

mmol/l

0.65

523

Other appendicitis

163

1.10

0.10

1.0

1.2

31.72

33.97

mmol/l

0.27

144

Endometriosis ASRM stages 3,4

515

1.05

0.10

1.2

29.88

33.81

mmol/l

0.85

431

Lichen planus, including avohilmo

486

1.05

0.10

1.1

36.45

33.54

mmol/l

0.32

410

Preterm labour and delivery

496

1.05

0.09

1.2

34.11

32.04

mmol/l

0.29

430

Mixed conductive and sensorineural hearing loss

301

1.06

0.09

1.2

35.20

34.64

mmol/l

0.06

255

Malignant neoplasm of breast, HER-negative

562

0.96

0.08

1.1

38.91

33.37

mmol/l

1.20

453

Mandibular retrognathia

126

1.11

0.08

1.7

2.8

38.93

35.94

mmol/l

0.17

121

Recurrent dislocation and subluxation of joint

113

0.88

0.08

2.0

1.2

33.40

37.35

mmol/l

—

101

Malignant neoplasm of other connective and soft tissue

0.83

0.08

1.0

1.4

24.52

36.94

mmol/l

—

Benign leiomyoma with endometriosis

430

0.95

0.08

1.0

1.1

31.40

33.59

mmol/l

0.25

357

Benign mammary dysplasia

381

1.05

0.08

1.1

37.11

33.66

mmol/l

0.33

314

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.06

0.08

1.0

1.2

48.66

36.12

mmol/l

—

Other enthesopathies

697

1.03

0.07

1.2

36.60

34.46

mmol/l

0.34

602

Carcinoma in situ, bladder

0.83

0.07

1.0

1.2

30.33

35.69

mmol/l

—

Maternal care for cervical incompetence

0.83

0.07

1.5

1.1

37.17

33.33

mmol/l

—

Cholecystectomy

216

1834

1.02

0.07

1.6

1.2

33.96

34.18

mmol/l

0.05

185

1553

Motorcycle rider injured in other and unspecified transport accidents

1.03

0.07

1.4

1.2

30.56

35.63

mmol/l

—

Medical abortion

177

977

0.98

0.07

1.2

32.32

33.01

mmol/l

0.15

145

834

0.87

0.06

2.8

1.3

36.25

35.07

mmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

413

1.04

0.06

1.1

1.2

34.77

34.20

mmol/l

0.05

348

Femoral hernia

103

0.87

0.06

1.1

32.11

34.32

mmol/l

—

Chronic suppurative otitis media

158

1.08

0.06

1.1

1.3

32.65

35.92

mmol/l

0.27

143

Endometriosis of ovary

356

1.04

0.06

1.3

1.1

30.92

32.78

mmol/l

0.24

305

Varicella [chickenpox]

119

1.09

0.05

1.3

1.7

34.86

38.33

mmol/l

0.26

114

Other menopausal disorders

411

0.97

0.05

1.3

1.1

30.98

32.42

mmol/l

0.23

353

Normotensive glaucoma

237

1.06

0.05

1.2

1.1

35.82

33.70

mmol/l

0.15

195

Tonsillectomy and adenotomy

121

828

1.02

0.04

1.4

1.7

30.75

35.10

mmol/l

1.41

113

739

Reactive arthropathies, FINNGEN

130

1.08

0.04

1.2

1.3

45.01

33.88

mmol/l

0.64

117

Chronic diseases of tonsils and adenoids

211

1348

0.99

0.04

1.3

1.4

31.22

34.38

mmol/l

1.34

190

1181

Primary open-angle glaucoma, strict

813

1.02

0.04

1.1

32.64

34.76

mmol/l

0.40

666

Other disorders of patella

329

1.03

0.03

1.4

1.2

29.69

37.06

mmol/l

1.20

283

L02BA Anti-estrogens

410

0.98

0.02

1.3

1.1

33.97

33.55

mmol/l

0.04

342

LSIL lesion of the cervix uteri

152

1.05

0.02

1.4

1.2

30.81

36.09

mmol/l

0.48

138

Nontoxic multinodular goitre

540

0.98

0.02

1.1

1.2

33.20

33.69

mmol/l

0.06

455

Mouth breathing

102

1029

0.99

0.02

1.7

1.3

33.97

35.30

mmol/l

0.22

903

Benign neoplasm: Choroid

133

1.05

0.01

1.0

1.1

28.43

33.93

mmol/l

0.63

117

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

133

1.05

0.01

1.7

1.2

34.93

36.31

mmol/l

0.09

119

Endometriosis

493

1.01

0.01

1.2

1.1

34.65

32.80

mmol/l

0.29

421

Dental pulpitis, including avohilmo

238

1537

1.00

0.01

1.4

1.2

30.77

34.58

mmol/l

1.99

203

1341

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

842

0.99

0.01

1.2

31.78

32.94

mmol/l

0.21

718

Nontoxic goitre/thyroid nodule

848

0.99

0.01

1.1

1.2

31.66

33.92

mmol/l

0.56

708

Primary gonarthrosis, bilateral

165

1406

1.00

0.01

1.2

1.1

35.57

33.97

mmol/l

0.40

136

1190

Other/unspecified reactive arthropathies

126

0.95

0.00

1.2

1.3

46.77

36.04

mmol/l

0.52

116

Persons encountering health services in circumstances related to reproduction

146

988

1.00

0.00

1.3

1.6

38.99

33.57

mmol/l

1.82

135

875

Tooth eruption problems

248

0.98

0.00

2.1

2.4

33.56

36.45

mmol/l

0.24

238

Nasal polyp

424

0.99

0.00

1.2

1.1

37.81

35.83

mmol/l

0.22

373

malignant neoplasm of male genital organs

411

1.01

0.00

1.1

1.2

36.95

34.26

mmol/l

0.55

351

L02BB Anti-androgens

208

1.01

0.00

1.1

44.89

36.57

mmol/l

1.21

175

Suggestive for eosinophilic asthma

195

0.97

0.00

1.1

36.69

35.04

mmol/l

0.16

171

Lichen ruber planus, wide definition including periferal and oral lichen planus

592

1.00

0.00

1.1

1.2

35.93

34.41

mmol/l

0.17

502

Urolithiasis

813

1.00

0.00

1.4

1.2

36.47

35.15

mmol/l

0.18

694

Follicular lymphoma, hilmo

103

0.97

0.00

1.2

36.00

33.98

mmol/l

—

Malignant neoplasm of prostate

395

1.00

0.00

1.1

1.2

36.57

34.15

mmol/l

0.46

335

Colour vision deficiencies

0.00

0.0

1.6

—

43.66

—

Thoracic root disorders

0.00

0.0

1.0

—

27.40

—

Carcinoma in situ of breast

0.00

0.0

1.1

—

25.00

—

Meningococcal infection

0.00

0.0

1.2

—

25.50

—

Osteomyelitis of vertebra

0.00

0.0

1.0

—

26.80

—

Fat embolism (traumatic)

0.00

0.0

1.0

—

39.50

—

Birth injury to scalp

0.00

-0.00

0.0

3.2

—

28.83

—

Melanocytic naevi of ear and external auricular canal

0.00

-0.00

0.0

1.0

—

37.88

—

Carcinoma in situ of skin of upper limb, including shoulder

0.87

-0.00

1.0

1.1

28.17

34.01

mmol/l

—

Malignant neoplasm of penis

0.00

-0.00

0.0

1.0

—

28.12

—

Liver disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

32.80

—

Posteruptive colour changes of dental hard tissues

0.00

-0.00

0.0

1.0

—

35.33

—

Other infective spondylopathies

0.00

-0.00

0.0

1.0

—

34.60

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.94

-0.00

2.3

1.1

40.50

34.24

mmol/l

—

Use of dimethyl fumarate

0.00

-0.00

0.0

1.1

—

35.14

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.2

—

35.67

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.0

—

30.00

—

Ophthalmic devices associated with adverse incidents

0.00

-0.00

0.0

1.0

—

37.00

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.2

—

22.40

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.0

—

33.40

—

Café au lait spots

0.00

-0.00

0.0

2.6

—

28.56

—

Osteochondrosis of ankle, juvenile

0.00

-0.00

0.0

1.0

—

37.17

—

Prepatellar bursitis

0.90

-0.00

1.3

27.71

35.47

mmol/l

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.0

—

32.60

—

Other and unspecified myoneural disorders

0.00

-0.00

0.0

1.0

—

43.06

—

Inhalation of gastric contents

0.00

-0.00

0.0

1.5

—

28.33

—

Use of fingolimod

0.00

-0.00

0.0

1.1

—

35.29

—

Radiodermatitis

0.00

-0.00

0.0

1.0

—

33.80

—

Pulmonary artery stenosis

0.00

-0.00

0.0

2.5

—

28.63

—

Mental and behavioural disorders due to hallucinogens

0.00

-0.00

0.0

1.2

—

31.83

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

-0.00

0.0

3.4

—

32.20

—

Use of teriflunomide

0.00

-0.00

0.0

1.1

—

37.13

—

Choroidal detachment

0.00

-0.00

0.0

1.0

—

23.50

—

Abnormal findings on antenatal screening of mother

0.98

-0.00

1.1

1.6

53.29

37.00

mmol/l

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

-0.00

0.0

1.0

—

36.60

—

Vaginal lichen planus

0.00

-0.00

0.0

1.1

—

28.11

—

Tuberous sclerosis 1

0.00

-0.00

0.0

1.0

—

33.43

—

Cytomegaloviral hepatitis

0.00

-0.00

0.0

1.0

—

30.40

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

1.0

—

25.75

—

Merkel cell carcinoma of skin

0.00

-0.00

0.0

1.0

—

25.00

—

Reiter disease

0.00

-0.00

0.0

1.0

—

27.50

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

-0.00

0.0

4.4

—

39.80

—

Other specified and unspecified disorders of iris and ciliary body

0.00

-0.00

0.0

1.0

—

25.14

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

1.0

—

40.29

—

Accessory breast

0.00

-0.00

0.0

1.2

—

33.67

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.8

—

31.25

—

Discontinuity and dislocation of ear ossicles

0.00

-0.00

0.0

1.0

—

39.29

—

Microcephaly

0.00

-0.00

0.0

2.0

—

33.00

—

Other disorders of carbohydrate metabolism

0.00

-0.00

0.0

3.4

—

43.57

—

Osteogenesis imperfecta

0.00

-0.00

0.0

1.0

—

29.14

—

Embolism and thrombosis of abdominal aorta

0.00

-0.00

0.0

1.0

—

29.60

—

Congenital malformations of nose

0.00

-0.00

0.0

1.8

—

24.40

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

27.00

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

2.7

—

35.00

—

Other vitreous opacities

0.92

-0.00

1.0

1.1

31.00

31.74

mmol/l

—

Other puerperal infections

0.93

-0.00

1.5

1.2

32.87

35.81

mmol/l

—

Chondrosarcoma

0.00

-0.00

0.0

1.1

—

28.11

—

Miliary tuberculosis

0.00

-0.00

0.0

1.0

—

52.46

—

Mucinous and mucinous cystic tumor

0.00

-0.00

0.0

1.0

—

28.00

—

Erythrasma

0.00

-0.00

0.0

1.0

—

29.83

—

Placental disorders

0.00

-0.00

0.0

1.2

—

23.40

—

Intrahepatic Cholestasis of Pregnancy (ICP)

1.01

-0.00

1.0

1.1

32.50

36.05

mmol/l

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

1.0

—

40.29

—

Birth injury to peripheral nervous system

0.00

-0.00

0.0

1.8

—

52.00

—

Microtia (small ears)

0.00

-0.00

0.0

3.4

—

26.40

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Potassium [Moles/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS